Induction	NN	nsubj	O
of	IN	case	O
Jurkat	NN	compound	B-cell_line
leukemic	JJ	amod	I-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
phorbol	NN	compound	O
12-myristate	NN	compound	O
13-acetate	NN	nmod	O
and	CC	cc	O
ionomycin	NN	conj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
the	DT	det	O
level	NN	dobj	O
of	IN	case	O
FKBP	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

To	TO	mark	O
investigate	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
accounting	VBG	acl	O
for	IN	case	O
the	DT	det	O
impaired	JJ	amod	O
responses	NNS	nmod	O
to	TO	case	O
gamma	NN	compound	B-protein
interferon	NN	nmod	I-protein
,	,	punct	O
a	DT	det	O
model	NN	compound	O
system	NN	appos	O
for	IN	mark	O
examining	VBG	acl	O
overall	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
protein	NN	compound	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
,	,	punct	O
activation	NN	nsubjpass	O
of	IN	case	O
Jak1	NN	nmod	B-protein
and	CC	cc	O
Jak2	NN	conj	B-protein
and	CC	cc	O
phosphorylation	NN	conj	O
of	IN	case	O
Stat1	NN	nmod	B-protein
was	VBD	auxpass	O
developed	VBN	ROOT	O
in	IN	case	O
phorbol	NN	nmod:npmod	B-cell_line
12-myristate	NN	nmod:npmod	I-cell_line
13-acetate-differentiated	JJ	amod	I-cell_line
U-937	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nsubjpass	I-protein
is	VBZ	auxpass	O
required	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
postinduction	NN	compound	O
repression	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
fibroblasts	NNS	nmod	B-cell_type
.	.	punct	O

Ectopic	JJ	amod	O
overexpression	NN	nsubj	O
of	IN	case	O
IRF-1	NN	nmod	B-protein
results	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
endogenous	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
for	IN	case	O
ICE	NN	nmod	B-protein
and	CC	cc	O
enhances	VBZ	conj	O
the	DT	det	O
sensitivity	NN	dobj	O
of	IN	case	O
cells	NNS	nmod	O
to	TO	case	O
radiation-induced	JJ	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

(	-LRB-	punct	O
v	LS	dep	O
)	-RRB-	punct	O
An	DT	det	O
EBNA-2-responsive	JJ	amod	B-DNA
element	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
found	VBN	ROOT	O
within	IN	case	O
the	DT	det	O
-512	CD	compound	B-DNA
to	TO	dep	I-DNA
+40	CD	nummod	I-DNA
LMP1	NN	compound	I-DNA
DNA	NN	nmod	I-DNA
since	IN	mark	O
this	DT	det	O
DNA	NN	nsubjpass	O
linked	VBN	acl	O
to	TO	case	O
a	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyltransferase	NN	compound	I-DNA
reporter	NN	compound	I-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
transactivated	VBN	advcl	O
by	IN	case	O
cotransfection	NN	nmod	O
with	IN	case	O
an	DT	det	O
EBNA-2	NN	compound	B-DNA
expression	NN	compound	I-DNA
vector	NN	nmod	I-DNA
.	.	punct	O

Because	IN	mark	O
insertion	NN	compound	O
mutations	NNS	nsubj	O
in	IN	case	O
phoP	NN	nmod	B-DNA
are	VBP	cop	O
polar	JJ	advcl	O
on	IN	case	O
phoQ	NN	nmod	B-DNA
,	,	punct	O
we	PRP	nsubj	O
constructed	VBD	ROOT	O
strains	NNS	dobj	O
that	WDT	nsubj	O
expressed	VBD	acl:relcl	O
the	DT	det	O
PhoQ	NN	compound	B-protein
protein	NN	dobj	I-protein
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
PhoP	NN	nmod	B-protein
to	TO	mark	O
test	VB	advcl	O
whether	IN	mark	O
resistance	NN	nsubj	O
to	TO	case	O
defensin	NN	nmod	O
requires	VBZ	ccomp	O
only	RB	advmod	O
the	DT	det	O
phoQ	NN	compound	B-protein
gene	NN	compound	I-protein
product	NN	dobj	I-protein
.	.	punct	O

The	DT	det	O
drug	NN	compound	O
concentrations	NNS	nsubjpass	O
required	VBN	acl	O
for	IN	case	O
antagonism	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
explained	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
relative	JJ	amod	O
affinity	NN	nmod	O
of	IN	case	O
the	DT	det	O
drugs	NNS	nmod	O
to	TO	dep	O
,	,	punct	O
and	CC	cc	O
by	IN	case	O
the	DT	det	O
abundance	NN	conj	O
of	IN	prep	O
,	,	punct	O
the	DT	det	O
immunophilin	NN	appos	B-protein
FKBP	NN	dep	B-protein
.	.	punct	O

Quantitation	NN	ROOT	O
of	IN	case	O
beta	NN	compound	B-RNA
1	CD	nummod	I-RNA
triiodothyronine	NN	compound	I-RNA
receptor	NN	compound	I-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
human	JJ	amod	O
tissues	NNS	nmod	O
by	IN	case	O
competitive	JJ	amod	O
reverse	JJ	amod	O
transcription	NN	compound	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	nmod	O
.	.	punct	O

To	TO	mark	O
understand	VB	advcl	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
leukemic	JJ	amod	B-cell_type
cell	NN	compound	I-cell_type
infiltration	NN	nmod	O
into	IN	case	O
organs	NNS	nmod	O
,	,	punct	O
we	PRP	nsubj	O
studied	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
and	CC	cc	O
regulation	NN	conj	O
of	IN	case	O
L-selectin	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
in	IN	case	O
fresh	JJ	amod	O
leukemic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
of	IN	case	O
adult	JJ	amod	O
T-cell	NN	compound	O
leukemia	NN	compound	O
(	-LRB-	punct	O
ATL	NN	appos	O
)	-RRB-	punct	O
patients	NNS	nmod	O
and	CC	cc	O
investigated	VBD	conj	O
the	DT	det	O
response	NN	dobj	O
of	IN	case	O
the	DT	det	O
L-selectin	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
to	TO	case	O
human	JJ	amod	B-protein
T-cell	NN	compound	I-protein
lymphotropic	JJ	amod	I-protein
virus	NN	compound	I-protein
type	NN	compound	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	I-protein
HTLV-1	NN	compound	I-protein
)	-RRB-	punct	I-protein
Tax	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
viral	JJ	amod	B-protein
transcriptional	JJ	amod	I-protein
transactivator	NN	acl:relcl	I-protein
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	FW	amod	O
vitro	FW	dep	O
mutagenesis	NN	nsubj	O
of	IN	case	O
the	DT	det	O
HTLV-I	NN	compound	O
rex	NN	compound	B-DNA
gene	NN	nmod	I-DNA
has	VBZ	aux	O
provided	VBN	ROOT	O
indirect	JJ	amod	O
evidence	NN	dobj	O
which	WDT	nsubj	O
suggests	VBZ	acl:relcl	O
that	IN	mark	O
p21rex	NN	nsubj	B-protein
,	,	punct	O
and	CC	cc	O
by	IN	case	O
analogy	NN	compound	O
HTLV-II	NN	compound	O
p24rex	NN	conj	B-protein
,	,	punct	O
results	VBZ	ccomp	O
from	IN	case	O
initiation	NN	nmod	O
at	IN	case	O
an	DT	det	O
internal	JJ	amod	O
AUG	NN	nmod	O
of	IN	case	O
the	DT	det	O
tax/rex	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
.	.	punct	O

The	DT	det	O
erythroid	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
erythroid	JJ	amod	B-protein
factor-1	NN	nsubj	I-protein
(	-LRB-	punct	O
EF1	NN	appos	B-protein
)	-RRB-	punct	O
plays	VBZ	ROOT	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
transcription	NN	nmod	O
of	IN	case	O
erythroid-specific	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

Flutamide	NN	nsubj	O
affects	VBZ	ROOT	O
androgen	NN	compound	B-protein
receptor	NN	compound	I-protein
behavior	NN	dobj	O
during	IN	case	O
the	DT	det	O
menstrual	JJ	amod	O
cycle	NN	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
these	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
nuclear	JJ	amod	O
TCF-1	NN	compound	B-protein
expression	NN	nsubj	O
can	MD	aux	O
serve	VB	ccomp	O
as	IN	case	O
a	DT	det	O
pan-T-lineage	JJ	amod	O
marker	NN	nmod	O
in	IN	case	O
the	DT	det	O
diagnosis	NN	nmod	O
of	IN	case	O
lymphoid	JJ	amod	O
malignancies	NNS	nmod	O
.	.	punct	O

A	DT	det	O
powerful	JJ	amod	O
enhancer	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
mapped	VBN	ROOT	O
to	TO	case	O
an	DT	det	O
18-bp	JJ	amod	B-DNA
DNA	NN	compound	I-DNA
segment	NN	nmod	I-DNA
located	JJ	amod	O
11	CD	nummod	O
kb	NN	nmod	O
5	CD	nummod	O
'	''	punct	O
to	TO	case	O
the	DT	det	O
human	JJ	amod	B-DNA
epsilon-globin	NN	compound	I-DNA
gene	NN	nmod	I-DNA
within	IN	case	O
the	DT	det	O
dominant	JJ	amod	B-DNA
control	NN	nmod	I-DNA
or	CC	cc	O
locus-activating	JJ	amod	B-DNA
region	NN	conj	I-DNA
.	.	punct	O

Transcriptional	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
TF	NN	compound	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
monocytic	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
exposed	VBN	acl	O
to	TO	case	O
bacterial	JJ	amod	O
lipopolysaccharide	NN	nmod	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
is	VBZ	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
binding	NN	nmod	O
of	IN	case	O
c-Rel/p65	NN	compound	B-protein
heterodimers	NNS	nmod	I-protein
to	TO	case	O
a	DT	det	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
site	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
TF	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Both	DT	det	O
LCLs	NNS	nsubjpass	B-cell_line
were	VBD	auxpass	O
found	VBN	ROOT	O
by	IN	case	O
EM	NN	nmod	O
to	TO	mark	O
produce	VB	xcomp	O
RVLP	NN	compound	O
and	CC	cc	O
EBV	NN	conj	O
particles	NNS	dobj	O
.	.	punct	O

Megakaryocytic	JJ	amod	B-cell_line
and	CC	cc	I-cell_line
erythrocytic	JJ	conj	I-cell_line
lineages	NNS	nsubj	I-cell_line
share	VBP	ROOT	O
specific	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	dobj	I-protein
.	.	punct	O

Transcriptional	JJ	amod	O
regulation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
gene	NN	nmod	O
encoding	VBG	acl	O
the	DT	det	O
human	JJ	amod	B-protein
C-type	JJ	amod	I-protein
lectin	NN	compound	I-protein
leukocyte	NN	compound	I-protein
receptor	NN	dobj	I-protein
AIM/CD69	NN	dep	B-protein
and	CC	cc	O
functional	JJ	amod	O
characterization	NN	conj	O
of	IN	case	O
its	PRP$	nmod:poss	O
tumor	NN	compound	B-DNA
necrosis	NN	nmod:npmod	I-DNA
factor-alpha-responsive	JJ	amod	I-DNA
elements	NNS	nmod	I-DNA
.	.	punct	O

The	DT	det	O
carboxyl-terminal	JJ	amod	B-protein
181	CD	nummod	I-protein
amino	NN	compound	I-protein
acids	NNS	nsubj	I-protein
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
TFIID	NN	compound	I-protein
protein	NN	nmod	I-protein
shares	VBZ	ROOT	O
80	CD	nummod	O
%	NN	compound	O
identity	NN	dobj	O
with	IN	case	O
the	DT	det	O
TFIID	NN	compound	B-protein
protein	NN	nmod	O
from	IN	case	O
Saccharomyces	FW	compound	O
cerevisiae	FW	nmod	O
.	.	punct	O

Data	NNS	nsubj	O
from	IN	case	O
cell	NN	compound	O
culture	NN	nmod	O
and	CC	cc	O
animal	NN	compound	O
studies	NNS	conj	O
indicate	VBP	ROOT	O
that	IN	mark	O
TR	NN	compound	B-protein
expression	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
regulated	VBN	ccomp	O
to	TO	mark	O
modulate	VB	xcomp	O
target	NN	compound	O
organ	NN	compound	O
responsiveness	NN	dobj	O
to	TO	case	O
thyroid	NN	compound	O
hormone	NN	nmod	O
.	.	punct	O

Some	DT	nsubj	O
of	IN	case	O
these	DT	det	O
proteins	NNS	nmod	O
(	-LRB-	punct	O
referred	VBN	dep	O
to	TO	nmod	O
as	IN	case	O
OTF-2	NN	nmod	B-protein
)	-RRB-	punct	O
are	VBP	cop	O
lymphoid	JJ	amod	O
specific	JJ	ROOT	O
,	,	punct	O
whereas	IN	dep	O
at	IN	case	O
least	JJS	nmod:npmod	O
one	CD	nummod	O
other	JJ	dep	O
,	,	punct	O
and	CC	cc	O
possibly	RB	advmod	O
more	JJR	conj	O
(	-LRB-	punct	O
referred	VBN	dep	O
to	TO	nmod	O
as	IN	case	O
OTF-1	NN	nmod	B-protein
)	-RRB-	punct	O
,	,	punct	O
is	VBZ	auxpass	O
found	VBN	conj	O
ubiquitously	RB	advmod	O
in	IN	case	O
all	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

Inducible	JJ	amod	O
nuclear	JJ	amod	B-protein
factor	NN	nsubjpass	I-protein
binding	VBG	acl	O
to	TO	case	O
the	DT	det	O
kappa	NN	compound	B-DNA
B	NN	compound	I-DNA
elements	NNS	nmod	I-DNA
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
immunodeficiency	NN	compound	I-DNA
virus	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
in	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
can	MD	aux	O
be	VB	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
cyclosporin	NN	compound	O
A	NN	nmod	O
in	IN	case	O
a	DT	det	O
signal-dependent	JJ	amod	O
manner	NN	nmod	O
.	.	punct	O

Domain	NN	compound	B-DNA
B	NN	nsubjpass	I-DNA
has	VBZ	aux	O
been	VBN	auxpass	O
described	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
B-cell-specific	JJ	amod	B-DNA
EB1-responsive	JJ	amod	I-DNA
element	NN	nmod	I-DNA
(	-LRB-	punct	O
P.M.Lieberman	NNP	dep	O
,	,	punct	O
J.M.Hardwick	NNP	conj	O
,	,	punct	O
and	CC	cc	O
S.D.Hayward	NNP	conj	O
,	,	punct	O
J.Virol.63	NNP	appos	O
:	:	punct	O
3040-3050	CD	dep	O
,	,	punct	O
1989	CD	amod	O
)	-RRB-	punct	O
activated	VBN	acl	O
synergistically	RB	advmod	O
by	IN	case	O
EB1	NN	nmod	B-protein
and	CC	cc	O
R	NN	conj	B-protein
,	,	punct	O
an	DT	det	O
EBV	NN	compound	B-protein
early	JJ	amod	I-protein
product	NN	appos	I-protein
encoded	VBN	acl	O
by	IN	case	O
the	DT	det	O
open	JJ	amod	B-DNA
reading	NN	compound	I-DNA
frame	NN	compound	I-DNA
BRLF1	NN	nmod	I-DNA
(	-LRB-	punct	O
M.A.	NNP	compound	O
Cox	NNP	dep	O
,	,	punct	O
J.Leahy	NNP	conj	O
,	,	punct	O
and	CC	cc	O
J.M.Hardwick	NNP	conj	O
,	,	punct	O
J.Virol.64	NNP	appos	O
:	:	punct	O
313-321	CD	dep	O
,	,	punct	O
1990	CD	amod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
amino-terminal	JJ	amod	B-protein
domain	NN	nsubj	I-protein
has	VBZ	ROOT	O
regions	NNS	dobj	O
homologous	JJ	amod	O
to	TO	case	O
the	DT	det	O
oncogene	NN	compound	B-DNA
rel	NN	nmod	I-DNA
and	CC	cc	O
to	TO	case	O
the	DT	det	O
developmentally	RB	advmod	O
important	JJ	amod	O
gene	NN	compound	O
dorsal	NN	conj	B-DNA
of	IN	case	O
Drosophila	FW	nmod	O
.	.	punct	O

Functional	JJ	amod	O
studies	NNS	nsubj	O
with	IN	case	O
IL-6	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
demonstrated	VBD	ROOT	O
that	IN	mark	O
three	CD	nummod	O
regions	NNS	nsubj	O
are	VBP	cop	O
the	DT	det	O
targets	NNS	ccomp	O
of	IN	case	O
the	DT	dep	O
IFN-gamma	NN	nmod	B-protein
and/or	CC	cc	O
TNF-alpha	NN	conj	B-protein
action	NN	dep	O
,	,	punct	O
whereas	IN	dep	O
only	RB	advmod	O
one	CD	nsubj	O
of	IN	case	O
these	DT	det	O
regions	NNS	nmod	O
seemed	VBN	advcl	O
to	TO	mark	O
be	VB	auxpass	O
implicated	VBN	xcomp	O
in	IN	case	O
LPS	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

In	IN	case	O
a	DT	det	O
non-parametric	JJ	amod	O
test	NN	nmod	O
(	-LRB-	punct	O
Kruskal-Wallis	NN	appos	O
)	-RRB-	punct	O
a	DT	det	O
strong	JJ	amod	O
negative	JJ	amod	O
association	NN	nsubjpass	O
was	VBD	auxpass	O
found	VBN	ROOT	O
between	IN	case	O
high	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
c-erbB2	NN	compound	B-DNA
amplification	NN	nmod	O
and	CC	cc	O
absence	NN	conj	O
of	IN	case	O
estrogen	NN	compound	O
receptor	NN	compound	O
(	-LRB-	punct	O
ER	NN	appos	O
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.0009	CD	dep	O
)	-RRB-	punct	O
or	CC	cc	O
progesterone	NN	compound	B-protein
receptor	NN	conj	I-protein
(	-LRB-	punct	O
PR	NN	appos	B-protein
)	-RRB-	punct	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
.011	CD	dep	O
)	-RRB-	punct	O
expression	NN	nmod	O
.	.	punct	O

In	IN	case	O
a	DT	det	O
series	NN	nmod	O
of	IN	case	O
functional	JJ	amod	O
studies	NNS	nmod	O
we	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
modulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
level	NN	nmod	O
of	IN	case	O
the	DT	det	O
mRNAs	NNS	nmod	B-RNA
coding	VBG	acl	O
for	IN	case	O
both	CC	cc:preconj	O
the	DT	det	O
c-myc	NN	compound	B-DNA
oncogene	NN	nmod	I-DNA
and	CC	cc	O
the	DT	det	O
growth	NN	compound	O
factor	NN	conj	O
known	VBN	acl	O
as	IN	case	O
granulocyte-monocyte	JJ	compound	O
colony	NN	compound	O
stimulating	NN	compound	O
activity	NN	nmod	O
by	IN	case	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	nmod	O
correlated	VBD	ccomp	O
with	IN	case	O
the	DT	det	O
1	CD	nummod	B-protein
,	,	punct	I-protein
25	CD	conj	I-protein
(	-LRB-	punct	I-protein
OH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2D3	NN	compound	I-protein
receptor	NN	compound	I-protein
status	NN	nmod	O
of	IN	case	O
these	DT	det	O
cells	NNS	nmod	O
.	.	punct	O

Two	CD	nummod	O
abundant	JJ	amod	O
proteins	NNS	nsubjpass	O
of	IN	case	O
75	CD	nummod	O
and	CC	cc	O
80	CD	conj	O
kD	NN	nmod	O
were	VBD	auxpass	O
competed	VBN	ROOT	O
out	RP	advmod	O
by	IN	case	O
poly	NN	amod	O
[	-LRB-	punct	O
d	NN	nmod	O
(	-LRB-	punct	O
I-C	NN	appos	O
)	-RRB-	punct	O
]	-RRB-	punct	O
in	IN	case	O
all	DT	det	O
reactions	NNS	nmod	O
.	.	punct	O

Significantly	RB	advmod	O
,	,	punct	O
CsA	NN	nsubj	O
completely	RB	advmod	O
suppressed	VBD	ROOT	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
NFAT	NN	nmod	B-protein
in	IN	case	O
endothelial	JJ	amod	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
inhibited	VBD	conj	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
granulocyte-macrophage	JJ	amod	B-DNA
colony-stimulating	JJ	amod	I-DNA
factor	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
GM-CSF	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	compound	I-DNA
regulatory	JJ	amod	I-DNA
elements	NNS	nmod	I-DNA
that	WDT	nsubj	O
use	VBP	acl:relcl	O
NFAT	NN	dobj	B-protein
by	IN	case	O
60	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
current	JJ	amod	O
study	NN	nmod	O
,	,	punct	O
cysteamine	NN	nsubjpass	O
,	,	punct	O
an	DT	det	O
aminothiol	NN	compound	O
compound	NN	appos	O
with	IN	case	O
antioxidant	JJ	amod	O
activity	NN	nmod	O
,	,	punct	O
has	VBZ	aux	O
been	VBN	auxpass	O
used	VBN	ROOT	O
to	TO	mark	O
further	RB	advmod	O
investigate	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
oxidative	JJ	amod	O
signalling	NN	nmod	O
during	IN	case	O
lymphocyte	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

Transcription	NN	compound	B-protein
factor	NN	compound	I-protein
IID	NN	nsubj	I-protein
(	-LRB-	punct	O
TFIID	NN	appos	B-protein
)	-RRB-	punct	O
binds	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
TATA	NN	compound	B-DNA
box	NN	compound	I-DNA
promoter	NN	compound	I-DNA
element	NN	nmod	I-DNA
and	CC	cc	O
regulates	VBZ	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
most	JJS	advmod	O
eukaryotic	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
transcribed	VBN	acl	O
by	IN	case	O
RNA	NN	compound	B-protein
polymerase	NN	nmod	I-protein
II	CD	nummod	I-protein
.	.	punct	O

A	DT	det	O
52-year-old	JJ	amod	O
male	JJ	nsubj	O
presented	VBD	ROOT	O
himself	PRP	dobj	O
with	IN	case	O
tachycardia	NN	compound	O
crises	NNS	nmod	O
which	WDT	nsubj	O
appeared	VBD	acl:relcl	O
first	RB	advmod	O
during	IN	case	O
childhood	NN	nmod	O
,	,	punct	O
increased	VBD	conj	O
in	IN	case	O
frequency	NN	nmod	O
without	IN	case	O
goiter	NN	nmod	O
or	CC	cc	O
exophthalmos	NN	conj	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
TNF-alpha	NN	nmod	B-protein
on	IN	case	O
gene	NN	compound	O
expression	NN	nmod	O
were	VBD	auxpass	O
examined	VBN	ROOT	O
by	IN	case	O
transient	JJ	amod	O
expression	NN	compound	O
assays	NNS	nmod	O
using	VBG	acl	O
reporter	NN	compound	B-DNA
chloramphenicol	NN	compound	I-DNA
acetyltransferase	NN	compound	I-DNA
plasmids	NNS	dobj	I-DNA
linked	VBN	acl	O
to	TO	case	O
regulatory	JJ	amod	B-DNA
elements	NNS	nmod	I-DNA
from	IN	case	O
the	DT	det	O
HIV	NN	compound	B-DNA
long	JJ	amod	I-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
beta	NN	compound	B-DNA
interferon	NN	compound	I-DNA
promoter	NN	conj	I-DNA
.	.	punct	O

Proteins	NNS	nsubj	O
in	IN	case	O
the	DT	det	O
second	JJ	amod	O
group	NN	nmod	O
carry	VBP	ROOT	O
a	DT	det	O
single	JJ	amod	B-protein
HMG	NN	compound	I-protein
box	NN	dobj	I-protein
with	IN	case	O
affinity	NN	nmod	O
for	IN	case	O
the	DT	det	O
minor	JJ	amod	O
groove	NN	nmod	O
of	IN	case	O
the	DT	det	O
heptamer	NN	compound	B-DNA
motif	NN	nmod	I-DNA
AACAAAG	NN	dep	O
or	CC	cc	O
variations	NNS	conj	O
thereof	RB	advmod	O
.	.	punct	O

Involvement	NN	ROOT	O
of	IN	case	O
a	DT	det	O
second	JJ	amod	O
lymphoid-specific	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
element	NN	nmod	I-DNA
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
heavy-chain	JJ	amod	I-DNA
gene	NN	compound	I-DNA
expression	NN	nmod	O
.	.	punct	O

The	DT	det	O
Oct-1	NN	compound	B-protein
protein	NN	nsubj	I-protein
is	VBZ	cop	O
present	JJ	ROOT	O
in	IN	case	O
all	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
analyzed	VBN	acl	O
so	RB	advmod	O
far	RB	advmod	O
,	,	punct	O
whereas	IN	mark	O
Oct-2A	NN	nsubjpass	B-protein
and	CC	cc	O
Oct-2B	NN	conj	B-protein
are	VBP	auxpass	O
found	VBN	advcl	O
mainly	RB	advmod	O
in	IN	case	O
B	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

The	DT	det	O
overexpression	NN	nsubj	O
of	IN	case	O
L-selectin	NN	nmod	B-protein
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
of	IN	case	O
inflammatory	JJ	amod	B-protein
cytokines	NNS	conj	I-protein
,	,	punct	O
by	IN	case	O
ATL	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
may	MD	aux	O
provide	VB	ROOT	O
a	DT	det	O
basis	NN	dobj	O
for	IN	case	O
ATL	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
to	TO	mark	O
attach	VB	acl	O
the	DT	det	O
vascular	JJ	amod	O
endothelium	NN	dobj	O
,	,	punct	O
leading	VBG	advcl	O
to	TO	case	O
transmigration	NN	nmod	O
and	CC	cc	O
organ	NN	compound	O
infitration	NN	conj	O
.	.	punct	O

The	DT	det	O
balance	NN	nsubj	O
between	IN	case	O
type	NN	nmod	O
1	CD	nummod	O
and	CC	cc	O
2	CD	conj	O
T	NN	compound	O
helper	NN	compound	O
cell	NN	compound	O
cytokine	NN	compound	O
production	NN	dep	O
plays	VBZ	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
several	JJ	amod	O
animal	NN	compound	O
models	NNS	nmod	O
of	IN	case	O
autoimmunity	NN	nmod	O
,	,	punct	O
and	CC	cc	O
skewed	JJ	amod	O
patterns	NNS	nsubjpass	O
of	IN	case	O
cytokine	NN	compound	B-protein
expression	NN	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
described	VBN	conj	O
in	IN	case	O
human	JJ	amod	O
inflammatory	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

CD30	NN	compound	B-protein
ligation	NN	nsubj	O
induces	VBZ	ROOT	O
nuclear	JJ	amod	B-protein
factor-kappa	NN	compound	I-protein
B	NN	compound	I-protein
activation	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

This	DT	det	O
gene	NN	nsubj	O
is	VBZ	ROOT	O
yet	RB	advmod	O
another	DT	attr	O
in	IN	case	O
a	DT	det	O
growing	VBG	amod	O
list	NN	nmod	O
of	IN	case	O
important	JJ	amod	O
regulatory	JJ	amod	O
molecules	NNS	nmod	O
whose	WP$	nmod:poss	O
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
transcriptionally	RB	advmod	O
induced	VBN	acl:relcl	O
upon	IN	case	O
cellular	JJ	amod	O
activation	NN	nmod	O
.	.	punct	O

Complementary	JJ	amod	B-DNA
DNA	NN	nsubjpass	I-DNA
(	-LRB-	punct	O
cDNA	NN	appos	B-DNA
)	-RRB-	punct	O
encoding	VBG	acl	O
a	DT	det	O
human	JJ	amod	B-protein
TFIID	NN	compound	I-protein
protein	NN	dobj	I-protein
has	VBZ	aux	O
been	VBN	auxpass	O
cloned	VBN	ROOT	O
.	.	punct	O

RU	NN	nsubj	O
486	CD	nummod	O
tested	VBN	acl	O
at	IN	case	O
an	DT	det	O
equal	JJ	amod	O
concentration	NN	nmod	O
as	IN	case	O
progesterone	NN	nmod	O
significantly	RB	advmod	O
inhibited	VBD	ROOT	O
the	DT	det	O
production	NN	dobj	O
of	IN	case	O
the	DT	det	O
blocking	NN	compound	B-protein
factor	NN	nmod	I-protein
,	,	punct	O
while	IN	mark	O
RU	NN	nsubj	O
43044	CD	nummod	O
was	VBD	cop	O
without	IN	case	O
effect	NN	advcl	O
.	.	punct	O

Each	DT	det	O
serum	NN	nsubj	O
contained	VBD	ROOT	O
antibodies	NNS	dobj	B-protein
to	TO	case	O
a	DT	det	O
different	JJ	amod	O
set	NN	nmod	O
of	IN	case	O
epitopes	NNS	nmod	B-protein
,	,	punct	O
which	WDT	nsubj	O
taken	VBN	acl:relcl	O
together	RB	advmod	O
cover	VBP	conj	O
most	JJS	dobj	O
of	IN	case	O
the	DT	det	O
HBx	NN	compound	B-protein
sequence	NN	nmod	I-protein
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
support	VBP	ROOT	O
the	DT	det	O
view	NN	dobj	O
that	IN	mark	O
steroid-mediated	JJ	amod	O
cell	NN	compound	O
death	NN	nsubj	O
occurs	VBZ	acl	O
by	IN	case	O
a	DT	det	O
process	NN	nmod	O
requiring	VBG	acl	O
direct	JJ	amod	O
interaction	NN	dobj	O
of	IN	case	O
steroid-receptor	JJ	amod	B-protein
complexes	NNS	nmod	I-protein
with	IN	case	O
the	DT	det	O
genome	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
TCL1	NN	compound	B-DNA
gene	NN	nsubjpass	I-DNA
was	VBD	auxpass	O
overexpressed	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
PBLs	NNS	nmod	B-cell_type
of	IN	case	O
an	DT	det	O
AT	JJ	amod	O
patient	NN	nmod	O
with	IN	case	O
a	DT	det	O
large	JJ	amod	B-cell_line
clonal	JJ	amod	I-cell_line
T-cell	NN	compound	I-cell_line
population	NN	nmod	I-cell_line
exhibiting	VBG	acl	O
the	DT	det	O
t	NN	compound	O
(	-LRB-	punct	O
14	CD	nummod	O
;	:	punct	O
14	CD	dep	O
)	-RRB-	punct	O
translocation	NN	dobj	O
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
the	DT	det	O
lymphocytes	NNS	conj	B-cell_type
of	IN	case	O
the	DT	det	O
other	JJ	amod	O
cases	NNS	nmod	O
.	.	punct	O

The	DT	det	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nsubjpass	O
is	VBZ	auxpass	O
initiated	VBN	ROOT	O
by	IN	case	O
interaction	NN	nmod	O
of	IN	case	O
specific	JJ	amod	O
Ags	NNS	nmod	B-protein
with	IN	case	O
TCR	NN	nmod	B-protein
,	,	punct	O
followed	VBN	advcl	O
by	IN	case	O
activation	NN	nmod	O
of	IN	case	O
intracellular	JJ	amod	O
biochemical	JJ	amod	O
events	NNS	nmod	O
leading	VBG	acl	O
to	TO	case	O
activation	NN	nmod	O
of	IN	case	O
several	JJ	amod	O
genes	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
decreased	VBN	amod	O
concentration	NN	nsubj	O
of	IN	case	O
VDR	NN	nmod	B-protein
secondary	JJ	amod	O
to	TO	case	O
persistent	JJ	amod	O
hypophosphatemia	NN	nmod	O
is	VBZ	cop	O
one	CD	ccomp	O
of	IN	case	O
the	DT	det	O
causes	NNS	nmod	O
of	IN	case	O
vitamin	NN	compound	O
D	NN	compound	O
resistance	NN	nmod	O
in	IN	case	O
XLH	NN	nmod	O
.	.	punct	O

Human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	nsubj	O
(	-LRB-	punct	O
HIV	NN	appos	O
)	-RRB-	punct	O
often	RB	advmod	O
causes	VBZ	ROOT	O
latent	JJ	amod	O
infection	NN	dobj	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
a	DT	det	O
competitive	JJ	amod	O
progesterone	NN	compound	O
antagonist	NN	nmod	O
(	-LRB-	punct	O
RU486	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
specific	JJ	amod	O
glucocorticoid	NN	compound	B-protein
receptor	NN	compound	I-protein
blocker	NN	conj	O
(	-LRB-	punct	O
RU43044	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
tested	VBN	ROOT	O
on	IN	case	O
the	DT	det	O
release	NN	nmod	O
of	IN	case	O
a	DT	det	O
blocking	VBG	amod	B-protein
factor	NN	nmod	I-protein
by	IN	case	O
progesterone-treated	JJ	amod	B-cell_line
pregnancy	NN	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

[	-LRB-	punct	O
The	DT	det	O
inhibitory	JJ	amod	O
effect	NN	ROOT	O
of	IN	case	O
hydrocortisone	NN	nmod	O
on	IN	case	O
the	DT	det	O
chemotactic	JJ	amod	O
migration	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
]	-RRB-	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
SE	NN	nsubj	B-protein
induce	VBP	ccomp	O
dynamic	JJ	amod	O
changes	NNS	dobj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	dep	O
and	CC	cc	O
signal	NN	compound	O
transduction	NN	conj	O
through	IN	case	O
the	DT	dep	O
IL-2	NN	compound	B-protein
receptor	NN	compound	I-protein
(	-LRB-	punct	I-protein
IL-2R	NN	compound	I-protein
)	-RRB-	punct	I-protein
beta	NN	nmod	I-protein
and	CC	cc	I-protein
gamma	NN	compound	I-protein
chains	NNS	conj	I-protein
(	-LRB-	punct	O
IL-2R	NN	compound	B-protein
beta	NN	dep	I-protein
and	CC	cc	O
IL-2R	NN	compound	B-protein
gamma	NN	conj	I-protein
)	-RRB-	punct	O
in	IN	case	O
human	JJ	amod	B-cell_line
antigen-specific	JJ	amod	I-cell_line
CD4+	JJ	amod	I-cell_line
T-cell	NN	compound	I-cell_line
lines	NNS	nmod	I-cell_line
.	.	punct	O

To	TO	aux	O
be	VB	ROOT	O
or	CC	cc	O
not	RB	neg	O
to	TO	aux	O
be	VB	conj	O
a	DT	det	O
responder	NN	attr	O
in	IN	case	O
T-cell	NN	compound	O
responses	NNS	nmod	O
:	:	punct	O
ubiquitous	JJ	amod	O
oligopeptides	NNS	dep	O
in	IN	case	O
all	DT	det	O
proteins	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
one	CD	nummod	O
palindrome	NN	nsubj	B-DNA
,	,	punct	O
either	CC	appos	O
alone	RB	advmod	O
or	CC	cc	O
duplicated	JJ	conj	O
,	,	punct	O
or	CC	cc	O
the	DT	det	O
overlapping	VBG	amod	B-DNA
palindromes	NNS	conj	I-DNA
did	VBD	aux	O
not	RB	neg	O
respond	VB	ROOT	O
to	TO	case	O
R	NN	nmod	O
.	.	punct	O

Lymphocytes	NNS	nsubj	B-cell_line
are	VBP	cop	O
particularly	RB	advmod	O
susceptible	JJ	ROOT	O
to	TO	case	O
DNA	NN	nmod:npmod	O
damage-induced	JJ	amod	O
apoptosis	NN	nmod	O
,	,	punct	O
a	DT	det	O
response	NN	dep	O
which	WDT	nsubj	O
may	MD	aux	O
serve	VB	acl:relcl	O
as	IN	case	O
a	DT	det	O
form	NN	nmod	O
of	IN	case	O
'altruistic	JJ	amod	O
suicide	NN	nmod	O
'	''	punct	O
to	TO	mark	O
counter	VB	xcomp	O
their	PRP$	nmod:poss	O
intrinsic	JJ	amod	O
high	JJ	amod	O
potential	NN	dobj	O
for	IN	case	O
mutation	NN	nmod	O
and	CC	cc	O
clonal	JJ	amod	O
expansion	NN	conj	O
.	.	punct	O

2	LS	dep	O
)	-RRB-	punct	O
The	DT	det	O
FI	NN	nsubj	O
of	IN	case	O
the	DT	det	O
chemotactic	JJ	amod	O
migration	NN	compound	O
rate	NN	nmod	O
of	IN	case	O
PMN	NN	nmod	B-cell_type
by	IN	case	O
cortisol	NN	nmod	O
also	RB	advmod	O
showed	VBD	ROOT	O
diurnal	JJ	amod	O
changes	NNS	dobj	O
which	WDT	nsubj	O
were	VBD	cop	O
synchronous	JJ	acl:relcl	O
with	IN	case	O
that	DT	nmod	O
of	IN	case	O
GR	NN	nmod	B-protein
.	.	punct	O

To	TO	mark	O
elucidate	VB	advcl	O
the	DT	det	O
mechanisms	NNS	dobj	O
that	WDT	nsubj	O
regulate	VBP	acl:relcl	O
the	DT	det	O
constitutive	JJ	amod	O
and	CC	cc	O
inducible	JJ	conj	O
expression	NN	dobj	O
of	IN	case	O
CD69	NN	nmod	B-protein
by	IN	case	O
leukocytes	NNS	nmod	B-cell_type
,	,	punct	O
we	PRP	nsubj	O
isolated	VBD	ROOT	O
the	DT	det	O
promoter	NN	compound	B-DNA
region	NN	dobj	I-DNA
of	IN	case	O
the	DT	det	O
CD69	NN	compound	B-protein
gene	NN	nmod	O
and	CC	cc	O
carried	VBD	conj	O
out	RP	prt	O
its	PRP$	nmod:poss	O
functional	JJ	amod	O
characterization	NN	dobj	O
.	.	punct	O

A	DT	det	O
strong	JJ	amod	O
repressor	NN	compound	B-protein
element	NN	nsubjpass	I-protein
,	,	punct	O
termed	VBN	acl	O
nuclear	JJ	amod	B-protein
inhibitory	JJ	amod	I-protein
protein	NN	xcomp	I-protein
(	-LRB-	punct	O
NIP	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
was	VBD	auxpass	O
previously	RB	advmod	O
mapped	VBN	ROOT	O
to	TO	case	O
a	DT	det	O
segment	NN	nmod	O
of	IN	case	O
the	DT	det	O
IL-3	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
between	IN	case	O
nucleotides	NNS	nmod	B-DNA
-271	CD	nummod	I-DNA
and	CC	cc	I-DNA
-250	CD	nummod	I-DNA
.	.	punct	O

Interaction	NN	nsubj	O
of	IN	case	O
fibronectin	NN	nmod	B-protein
with	IN	case	O
VLA-5	NN	compound	B-protein
receptor	NN	nmod	I-protein
on	IN	case	O
CD4	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
induces	VBZ	ROOT	O
the	DT	det	O
AP-1	NN	compound	B-protein
transcription	NN	compound	I-protein
factor	NN	dobj	I-protein
.	.	punct	O

These	DT	det	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
CVZ	NN	nsubj	O
is	VBZ	aux	O
recognizing	VBG	ccomp	O
two	CD	nummod	O
glucocorticoid	NN	compound	B-protein
binding	NN	compound	I-protein
sites	NNS	dobj	I-protein
on	IN	case	O
the	DT	det	O
human	JJ	amod	O
GR	NN	nmod	B-protein
or	CC	cc	O
a	DT	det	O
protein	NN	conj	O
very	RB	advmod	O
similar	JJ	amod	O
to	IN	case	O
it	PRP	nmod	O
.	.	punct	O

Sex	NN	compound	O
steroid	NN	compound	O
regulation	NN	nsubj	O
of	IN	case	O
the	DT	det	O
production	NN	nmod	O
of	IN	case	O
this	DT	det	O
molecule	NN	nmod	O
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
other	JJ	amod	O
cytokines	NNS	conj	B-protein
,	,	punct	O
may	MD	aux	O
help	VB	ROOT	O
explain	VB	xcomp	O
the	DT	det	O
gender-specific	JJ	amod	O
differences	NNS	dobj	O
in	IN	case	O
the	DT	det	O
immune	JJ	amod	O
system	NN	nmod	O
,	,	punct	O
including	VBG	case	O
autoimmunity	NN	nmod	O
.	.	punct	O

Binding	NN	ROOT	O
of	IN	case	O
[	-LRB-	punct	O
3H	NN	dep	O
]	-RRB-	punct	O
VD3	NN	nsubj	O
was	VBD	cop	O
saturable	JJ	nmod	O
,	,	punct	O
with	IN	case	O
approximately	RB	advmod	O
2000-3000	CD	nummod	O
sites/cell	NNS	nmod	O
,	,	punct	O
and	CC	cc	O
half-maximal	JJ	amod	O
binding	NN	conj	O
occurring	VBG	acl	O
at	IN	case	O
0.21-0.33	CD	nummod	O
nM	NN	nmod	O
.	.	punct	O

Both	DT	nsubjpass	O
of	IN	case	O
these	DT	det	O
events	NNS	nmod	O
were	VBD	auxpass	O
blocked	VBN	ROOT	O
by	IN	case	O
preincubation	NN	nmod	O
of	IN	case	O
the	DT	det	O
cells	NNS	nmod	O
with	IN	case	O
FK506	NN	nmod	O
,	,	punct	O
a	DT	det	O
calcineurin	NN	compound	B-protein
inhibitor	NN	appos	O
,	,	punct	O
consistent	JJ	advcl	O
with	IN	case	O
the	DT	det	O
hypothesis	NN	nmod	O
that	IN	mark	O
NFATp	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
calcineurin	NN	compound	B-protein
substrate	NN	ccomp	O
in	IN	case	O
cells	NNS	nmod	O
.	.	punct	O

The	DT	det	O
differentiation	NN	nsubjpass	O
of	IN	case	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
into	IN	case	O
functionally	RB	advmod	O
diverse	JJ	amod	O
subpopulations	NNS	nmod	O
is	VBZ	auxpass	O
controlled	VBN	ROOT	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
by	IN	case	O
transcriptional	JJ	amod	O
activation	NN	nmod	O
and	CC	cc	O
silencing	NN	conj	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
little	JJ	nsubjpass	O
is	VBZ	auxpass	O
known	VBN	parataxis	O
in	IN	case	O
detail	NN	nmod	O
about	IN	case	O
the	DT	det	O
proteins	NNS	nmod	O
that	WDT	nsubj	O
influence	VBP	acl:relcl	O
this	DT	det	O
developmental	JJ	amod	O
process	NN	dobj	O
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
this	DT	det	O
study	NN	nsubj	O
demonstrates	VBZ	ROOT	O
that	IN	mark	O
AML-1B	NN	nsubj	B-protein
can	MD	aux	O
increase	VB	ccomp	O
gene	NN	compound	O
expression	NN	dobj	O
of	IN	case	O
an	DT	det	O
osteoblast-specific	JJ	amod	B-DNA
gene	NN	nmod	I-DNA
through	IN	case	O
its	PRP$	nmod:poss	O
binding	NN	nmod	O
to	TO	case	O
an	DT	det	O
osteoblast-specific	JJ	amod	B-DNA
cis-acting	JJ	amod	I-DNA
element	NN	nmod	I-DNA
and	CC	cc	O
presents	VBZ	conj	O
evidence	NN	dobj	O
that	IN	mark	O
OSF2	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
member	NN	ccomp	O
of	IN	case	O
the	DT	det	O
PEBP2	NN	compound	B-protein
alpha/AML-1	NN	compound	I-protein
family	NN	nmod	I-protein
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
c-jun	NN	compound	B-DNA
gene	NN	compound	I-DNA
expression	NN	nsubj	O
was	VBD	cop	O
very	RB	advmod	O
transient	JJ	ROOT	O
and	CC	cc	O
was	VBD	cop	O
not	RB	neg	O
detectable	JJ	conj	O
by	IN	case	O
60	CD	nummod	O
min	NN	nmod	O
after	IN	case	O
M-CSF	NN	compound	B-protein
addition	NN	nmod	O
.	.	punct	O

Phosphorylation	NN	nsubj	O
of	IN	case	O
Jak2	NN	nmod	B-protein
in	IN	case	O
tax	NN	compound	B-cell_line
transformed	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
resulted	VBD	ROOT	O
from	IN	case	O
high	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
IL-6	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
there	EX	expl	O
is	VBZ	ROOT	O
an	DT	det	O
EB1-binding	JJ	amod	B-DNA
site	NN	nsubj	I-DNA
(	-LRB-	punct	O
ZRE-B	NN	appos	B-DNA
)	-RRB-	punct	O
located	JJ	amod	O
within	IN	case	O
the	DT	det	O
R-responsive	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
region	NN	nmod	I-DNA
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
previously	RB	advmod	O
reported	VBN	ROOT	O
that	IN	mark	O
human	JJ	amod	B-cell_type
peripheral	JJ	amod	I-cell_type
blood	NN	compound	I-cell_type
mononuclear	JJ	amod	I-cell_type
cells	NNS	nsubj	I-cell_type
(	-LRB-	punct	O
PBMC	NNS	appos	B-cell_type
)	-RRB-	punct	O
contain	VBP	ccomp	O
type	NN	compound	O
II	CD	nummod	B-protein
estrogen	NN	compound	I-protein
binding	NN	compound	I-protein
sites	NNS	dobj	I-protein
(	-LRB-	punct	O
type	NN	compound	B-protein
II	CD	nummod	I-protein
EBS	NNS	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

After	IN	case	O
16	CD	nummod	O
hr	NN	nmod	O
of	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
SE	NN	nmod	B-protein
,	,	punct	O
the	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
IL-2R	NN	compound	B-protein
beta	NN	nmod	I-protein
remained	VBD	ROOT	O
low	JJ	xcomp	O
,	,	punct	O
while	IN	mark	O
that	DT	nsubjpass	O
of	IN	case	O
IL2R	NN	compound	B-protein
alpha	NN	nmod	I-protein
and	CC	cc	O
IL2R	NN	compound	B-protein
gamma	NN	conj	I-protein
was	VBD	auxpass	O
further	RB	advmod	O
up-regulated	VBN	advcl	O
,	,	punct	O
and	CC	cc	O
ligand-induced	JJ	amod	O
tyrosine	NN	compound	O
phosphorylation	NN	nsubjpass	O
of	IN	case	O
Jak3	NN	nmod	B-protein
and	CC	cc	O
Stat	NN	compound	B-protein
proteins	NNS	conj	I-protein
was	VBD	auxpass	O
partly	RB	advmod	O
normalized	VBN	conj	O
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
identified	VBD	ROOT	O
the	DT	det	O
DNA	NN	compound	B-DNA
consensus	NN	compound	I-DNA
binding	NN	compound	I-DNA
site	NN	dobj	I-DNA
recognized	VBN	acl	O
by	IN	case	O
the	DT	det	O
two	CD	nummod	O
DNA	NN	compound	B-protein
binding	NN	compound	I-protein
domains	NNS	nmod	I-protein
.	.	punct	O

In	IN	case	O
our	PRP$	nmod:poss	O
attempt	NN	nmod	O
to	TO	mark	O
identify	VB	acl	O
chemokine	NN	compound	B-protein
receptors	NNS	dobj	I-protein
that	WDT	nsubj	O
are	VBP	cop	O
related	JJ	acl:relcl	O
to	TO	case	O
Burkitt	NN	nmod:poss	B-protein
's	POS	case	I-protein
lymphoma	NN	compound	I-protein
receptor	NN	nmod	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	O
BLR1	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
are	VBP	auxpass	O
expressed	VBN	conj	O
in	IN	case	O
activated	VBN	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
we	PRP	nsubj	O
used	VBD	ROOT	O
RT-PCR	NN	dobj	O
resulting	VBG	acl	O
in	IN	case	O
the	DT	det	O
isolation	NN	nmod	O
of	IN	case	O
a	DT	det	O
cDNA	NN	nmod	O
encoding	VBG	acl	O
a	DT	det	O
seven	CD	nummod	B-protein
transmembrane	NN	compound	I-protein
receptor	NN	dobj	I-protein
termed	VBN	acl	O
BLR2	NN	xcomp	B-protein
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
CCAAT	NN	compound	B-DNA
site	NN	nsubjpass	I-DNA
located	JJ	amod	O
upstream	RB	advmod	O
of	IN	case	O
the	DT	det	O
PU.1	NN	compound	B-DNA
site	NN	nmod	I-DNA
between	IN	case	O
positions	NNS	nmod	O
-70	CD	nummod	O
and	CC	cc	O
-54	CD	conj	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
positive-negative	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
receptor	NN	compound	I-DNA
alpha	NN	compound	I-DNA
promoter	NN	compound	I-DNA
activity	NN	nmod	O
.	.	punct	O

Activity	NN	nsubj	O
of	IN	case	O
the	DT	det	O
immunoglobulin	NN	nmod	B-DNA
heavy	JJ	dep	I-DNA
and	CC	cc	I-DNA
kappa	NN	compound	I-DNA
light	JJ	amod	I-DNA
chain	NN	compound	I-DNA
gene	NN	compound	I-DNA
enhancers	NNS	dep	I-DNA
depends	VBZ	ROOT	O
on	IN	case	O
a	DT	det	O
complex	JJ	amod	O
interplay	NN	nmod	O
of	IN	case	O
ubiquitous	JJ	amod	B-protein
and	CC	cc	I-protein
developmentally	RB	advmod	I-protein
regulated	VBN	conj	I-protein
proteins	NNS	nmod	I-protein
.	.	punct	O

The	DT	det	O
immunoglobulin	NN	compound	B-protein
heavy	JJ	amod	I-protein
chain	NN	compound	I-protein
(	-LRB-	punct	O
IgH	NN	appos	B-protein
)	-RRB-	punct	O
intronic	JJ	amod	O
enhancer	NN	nsubj	O
stimulates	VBZ	ROOT	O
transcription	NN	dobj	O
from	IN	case	O
functional	JJ	amod	O
promoters	NNS	nmod	O
in	IN	case	O
B	NN	compound	O
lymphocytes	NNS	nmod	O
but	CC	cc	O
not	RB	cc	O
other	JJ	amod	O
cell	NN	compound	O
types	NNS	conj	O
.	.	punct	O

This	DT	det	O
region	NN	nsubj	O
(	-LRB-	punct	O
termed	VBN	acl	O
the	DT	det	O
zinc	NN	compound	B-DNA
finger	NN	compound	I-DNA
protein	NN	compound	I-DNA
binding	NN	compound	I-DNA
region	NN	xcomp	I-DNA
(	-LRB-	punct	O
ZIP	NN	appos	B-DNA
)	-RRB-	punct	O
)	-RRB-	punct	O
serves	VBZ	ROOT	O
as	IN	case	O
binding	VBG	amod	O
site	NN	nmod	O
for	IN	case	O
two	CD	nummod	O
differently	RB	advmod	O
regulated	VBN	amod	O
zinc	NN	compound	B-protein
finger	NN	compound	I-protein
proteins	NNS	nmod	I-protein
:	:	punct	O
the	DT	det	O
constitutively	RB	advmod	B-protein
expressed	VBN	amod	I-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
Sp1	NN	dep	B-protein
and	CC	cc	O
the	DT	det	O
inducible	JJ	amod	B-protein
early	JJ	amod	I-protein
growth	NN	compound	I-protein
response	NN	compound	I-protein
protein	NN	compound	I-protein
EGR-1	NN	conj	B-protein
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
NF-kappa	NN	compound	B-protein
B	NN	compound	I-protein
activity	NN	nsubjpass	O
was	VBD	auxpass	O
not	RB	neg	O
detected	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
following	VBG	case	O
long-term	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
Tax	NN	nmod	B-protein
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

Mutational	JJ	amod	O
analyses	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
HIV-1	NN	compound	B-DNA
LTR	NN	nmod	I-DNA
showed	VBD	ROOT	O
that	IN	mark	O
one	CD	nummod	O
C/EBP	NN	compound	B-DNA
site	NN	nsubjpass	I-DNA
is	VBZ	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
normal	JJ	amod	O
LTR	NN	compound	B-DNA
transcription	NN	nmod	O
both	CC	cc:preconj	O
before	IN	nmod	O
and	CC	cc	O
after	IN	conj	O
cellular	JJ	amod	O
activation	NN	nmod	O
and	CC	cc	O
that	IN	mark	O
the	DT	det	O
two	CD	nummod	O
3	CD	nummod	O
'	``	punct	O
C/EBP	NN	compound	B-DNA
sites	NNS	nsubj	I-DNA
are	VBP	cop	O
functionally	RB	advmod	O
equivalent	JJ	conj	O
.	.	punct	O

Tax	NN	nmod:npmod	B-protein
-independent	JJ	amod	O
binding	NN	ROOT	O
of	IN	case	O
multiple	JJ	amod	O
cellular	JJ	amod	B-protein
factors	NNS	nmod	I-protein
to	TO	case	O
Tax-response	JJ	amod	B-DNA
element	NN	compound	I-DNA
DNA	NN	nmod	I-DNA
of	IN	case	O
HTLV-I	NN	nmod	O
.	.	punct	O

Similar	JJ	amod	O
findings	NNS	nsubjpass	O
were	VBD	auxpass	O
obtained	VBN	ROOT	O
with	IN	case	O
bryostatin	NN	nmod	O
1	CD	nummod	O
(	-LRB-	punct	O
10	CD	nummod	O
nM	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
another	DT	det	O
activator	NN	appos	O
of	IN	case	O
protein	NN	compound	B-protein
kinase	NN	compound	I-protein
C	NN	nmod	I-protein
and	CC	cc	O
inducer	NN	conj	O
of	IN	case	O
monocytic	JJ	amod	O
differentiation	NN	nmod	O
.	.	punct	O

Order	NN	nsubj	O
of	IN	case	O
addition	NN	nmod	O
and	CC	cc	O
off-rate	JJ	amod	O
experiments	NNS	conj	O
indicate	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
VDR-retinoid	NN	compound	B-protein
X	NN	compound	I-protein
receptor	NN	compound	I-protein
heterodimer	NN	nsubj	I-protein
blocks	VBZ	ccomp	O
NFATp/AP-1	NN	compound	B-protein
complex	NN	compound	I-protein
formation	NN	dobj	O
and	CC	cc	O
then	RB	advmod	O
stably	RB	advmod	O
associates	VBZ	conj	O
with	IN	case	O
the	DT	det	O
NF-AT-1	NN	compound	B-DNA
element	NN	nmod	I-DNA
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
HL-60	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
with	IN	case	O
both	CC	cc:preconj	O
TPA	NN	nmod	O
and	CC	cc	O
cycloheximide	NN	conj	O
had	VBD	ROOT	O
no	DT	neg	O
effect	NN	dobj	O
on	IN	case	O
the	DT	det	O
rates	NNS	nmod	O
of	IN	case	O
c-jun	NN	compound	B-DNA
transcription	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
CD69	NN	nmod	B-protein
can	MD	aux	O
be	VB	auxpass	O
induced	VBN	advcl	O
in	FW	compound	O
vitro	FW	advmod	O
on	IN	case	O
cells	NNS	nmod	O
of	IN	case	O
most	JJS	advmod	O
hematopoietic	JJ	amod	O
lineages	NNS	nmod	O
with	IN	case	O
a	DT	det	O
wide	JJ	amod	O
variety	NN	nmod	O
of	IN	case	O
stimuli	NNS	nmod	O
,	,	punct	O
in	FW	compound	O
vivo	FW	advmod	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
mainly	RB	advmod	O
expressed	VBN	ROOT	O
by	IN	case	O
T-lymphocytes	NNS	nmod	B-cell_type
located	JJ	amod	O
in	IN	case	O
the	DT	det	O
inflammatory	JJ	amod	O
infiltrates	NNS	nmod	O
of	IN	case	O
several	JJ	amod	O
human	JJ	amod	O
diseases	NNS	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
examination	NN	nmod	O
of	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
autoimmunity	NN	nmod	O
in	IN	case	O
transgenic	JJ	amod	O
mice	NNS	nmod	O
,	,	punct	O
evidence	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
obtained	VBN	ROOT	O
further	RB	advmod	O
implicating	VBG	xcomp	O
the	DT	det	O
lymphokine	NN	compound	B-protein
interferon-gamma	NN	dobj	B-protein
in	IN	case	O
the	DT	det	O
etiology	NN	nmod	O
of	IN	case	O
autoimmunity	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
I	NN	compound	O
kappa	NN	compound	O
b	NN	compound	O
beta	NN	nsubjpass	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	conj	I-protein
,	,	punct	O
is	VBZ	auxpass	O
required	VBN	ccomp	O
for	IN	case	O
the	DT	det	O
signal-dependent	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
in	IN	case	O
fibroblasts	NNS	nmod	B-cell_type
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
we	PRP	nsubj	O
have	VBP	aux	O
asked	VBN	ROOT	O
which	WDT	mark	O
region	NN	compound	O
(	-LRB-	punct	O
s	NNS	nsubj	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
steroid	NN	compound	B-protein
receptor	NN	nmod	I-protein
are	VBP	cop	O
important	JJ	ccomp	O
for	IN	mark	O
mediating	VBG	advcl	O
lysis	NN	dobj	O
in	IN	case	O
leukemic	JJ	amod	B-cell_type
T	NN	compound	I-cell_type
lymphoblasts	NNS	nmod	I-cell_type
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
describe	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
regulatory	JJ	amod	B-DNA
element	NN	dobj	I-DNA
within	IN	case	O
the	DT	det	O
IL-2	NN	compound	B-DNA
promoter	NN	nmod	I-DNA
located	JJ	amod	O
immediately	RB	advmod	O
upstream	RB	advmod	O
of	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-DNA
factor	NN	compound	I-DNA
of	IN	amod	I-DNA
activated	VBN	amod	I-DNA
T	NN	compound	I-DNA
cell	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
NFAT	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
domain	NN	nmod	I-DNA
.	.	punct	O

The	DT	det	O
genomic	JJ	amod	O
actions	NNS	nsubjpass	O
of	IN	case	O
1	CD	nummod	O
,	,	punct	O
25-dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
(	-LRB-	punct	O
1	CD	nummod	O
,	,	punct	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
2D3	NN	appos	O
)	-RRB-	punct	O
are	VBP	auxpass	O
mediated	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
intracellular	JJ	amod	O
vitamin	NN	compound	B-protein
D	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
VDR	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

Two	CD	nummod	O
types	NNS	nsubjpass	O
of	IN	case	O
responses	NNS	nmod	O
were	VBD	auxpass	O
compared	VBN	ROOT	O
after	IN	case	O
a	DT	det	O
single	JJ	amod	O
MP	NN	compound	O
dose	NN	nmod	O
(	-LRB-	punct	O
40	CD	compound	O
mg	NN	nummod	O
bolus	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
divided	JJ	amod	O
regimen	NNS	conj	O
(	-LRB-	punct	O
20	CD	compound	O
mg	NN	nummod	O
bolus	NN	dep	O
and	CC	cc	O
a	DT	det	O
5	CD	compound	O
mg	NN	nummod	O
bolus	NN	conj	O
8	CD	nummod	O
hours	NNS	npadvmod	O
later	RB	advmod	O
)	-RRB-	punct	O
in	IN	case	O
six	CD	nummod	O
healthy	JJ	amod	O
male	JJ	amod	O
volunteers	NNS	nmod	O
.	.	punct	O

Both	DT	nsubj	O
encode	VBP	ROOT	O
proteins	NNS	dobj	O
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
specifically	RB	advmod	O
to	TO	case	O
a	DT	det	O
cAMP	NN	compound	B-DNA
response	NN	compound	I-DNA
element	NN	nmod	I-DNA
in	FW	compound	I-DNA
vitro	FW	advmod	I-DNA
.	.	punct	O

Promoter	NN	compound	O
deletion	NN	compound	O
studies	NNS	nsubj	O
revealed	VBD	ROOT	O
two	CD	nummod	O
additional	JJ	amod	O
NF-IL6	NN	compound	B-DNA
binding	NN	compound	I-DNA
sites	NNS	dobj	I-DNA
located	JJ	amod	O
at	IN	case	O
positions	NNS	nmod	O
-44	CD	compound	O
to	TO	dep	O
-36	CD	nummod	O
(	-LRB-	punct	O
C/EBP	NN	appos	B-protein
proximal	JJ	amod	I-protein
)	-RRB-	punct	O
and	CC	cc	O
-87	CD	compound	O
to	TO	dep	O
-79	CD	conj	O
(	-LRB-	punct	O
C/EBP	NN	appos	B-protein
medial	JJ	amod	I-protein
)	-RRB-	punct	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Since	IN	mark	O
many	JJ	amod	O
cytokines	NNS	nsubj	B-protein
that	WDT	nsubj	O
activate	VBP	acl:relcl	O
Jak	NN	compound	B-protein
kinases	NNS	dobj	I-protein
also	RB	advmod	O
lead	VBP	advcl	O
to	TO	case	O
the	DT	det	O
tyrosine	NN	compound	O
phosphorylation	NN	nmod	O
and	CC	cc	O
activation	NN	conj	O
of	IN	case	O
members	NNS	nmod	O
of	IN	case	O
the	DT	det	O
Stat	NN	compound	B-protein
family	NN	nmod	I-protein
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
,	,	punct	O
the	DT	det	O
ability	NN	nsubjpass	O
of	IN	case	O
IL-2	NN	nmod	B-protein
to	TO	mark	O
trigger	VB	acl	O
Stat	NN	compound	O
phosphorylation	NN	dobj	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
250	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

This	DT	nsubjpass	O
was	VBD	auxpass	O
followed	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
gradual	JJ	amod	O
decline	NN	nmod	O
to	TO	case	O
the	DT	det	O
basal	JJ	amod	O
level	NN	nmod	O
by	IN	case	O
24	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

The	DT	det	O
evolutionarily	RB	advmod	O
conserved	VBN	amod	O
N-terminal	JJ	amod	B-protein
half	NN	nsubj	I-protein
of	IN	case	O
IBR/F	NN	nmod	B-protein
harbors	VBZ	ROOT	O
the	DT	det	O
DNA-binding/dimerization	JJ	amod	B-protein
domain	NN	dobj	I-protein
(	-LRB-	punct	O
outer	JJ	amod	O
limits	NNS	dep	O
,	,	punct	O
127	CD	compound	O
to	TO	dep	O
283	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
one	CD	nummod	O
or	CC	cc	O
several	JJ	conj	O
casein	NN	compound	B-protein
kinase	NN	compound	I-protein
II	CD	nummod	I-protein
sites	NNS	conj	I-protein
(	-LRB-	punct	O
37	CD	compound	O
to	TO	dep	O
67	CD	dep	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
a	DT	det	O
bipartite	JJ	amod	B-protein
nuclear	JJ	amod	I-protein
localization	NN	compound	I-protein
signal	NN	conj	I-protein
(	-LRB-	punct	O
89	CD	nummod	O
to	TO	dep	O
106	CD	dep	O
)	-RRB-	punct	O
which	WDT	nsubj	O
appears	VBZ	acl:relcl	O
to	TO	mark	O
be	VB	cop	O
necessary	JJ	xcomp	O
for	IN	case	O
nuclear	JJ	amod	O
targeting	NN	nmod	O
.	.	punct	O

Absolute	JJ	amod	O
hTR	NN	compound	B-RNA
beta	NN	compound	I-RNA
1	CD	nummod	I-RNA
mRNA	NN	compound	I-RNA
levels	NNS	nsubj	O
are	VBP	cop	O
very	RB	advmod	O
low	JJ	ROOT	O
with	IN	case	O
an	DT	det	O
estimated	VBN	amod	O
one	CD	nummod	O
molecule	NN	nmod	O
of	IN	case	O
mRNA	NN	nmod	B-RNA
being	VBG	cop	O
present	JJ	xcomp	O
in	IN	case	O
a	DT	det	O
mononuclear	JJ	amod	B-cell_type
blood	NN	compound	I-cell_type
cell	NN	nmod	I-cell_type
or	CC	cc	O
thyrocyte	NN	conj	B-cell_type
.	.	punct	O

Vitamin	NN	compound	O
E	NN	compound	O
therapy	NN	nsubjpass	O
of	IN	case	O
acute	JJ	amod	O
CCl4-induced	JJ	amod	O
hepatic	JJ	amod	O
injury	NN	nmod	O
in	IN	case	O
mice	NNS	nmod	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
inhibition	NN	nmod	O
of	IN	case	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
binding	NN	nmod	O
.	.	punct	O

The	DT	det	O
N	NN	compound	B-DNA
element	NN	nsubj	I-DNA
could	MD	aux	O
independently	RB	advmod	O
mediate	VB	ROOT	O
low	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
transcription	NN	nmod	O
in	IN	case	O
both	CC	cc:preconj	O
B-cell	NN	nmod	O
and	CC	cc	O
HeLa-cell	JJ	conj	O
extracts	NNS	dep	O
,	,	punct	O
and	CC	cc	O
,	,	punct	O
in	IN	case	O
conjunction	NN	nmod	O
with	IN	case	O
the	DT	det	O
octamer	NN	compound	B-DNA
element	NN	nmod	I-DNA
,	,	punct	O
it	PRP	nsubj	O
can	MD	aux	O
promote	VB	conj	O
high	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
transcription	NN	nmod	O
in	IN	case	O
B-cell	NN	compound	O
extracts	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
role	NN	dobj	O
for	IN	case	O
altered	JJ	amod	O
balance	NN	nmod	O
of	IN	case	O
Stat1	NN	compound	O
and	CC	cc	O
Stat3	NN	conj	O
transcriptional	JJ	amod	O
activity	NN	nmod	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
T	NN	compound	B-cell_type
cell	NN	compound	I-cell_type
differentiation	NN	nmod	O
and	CC	cc	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	conj	O
of	IN	case	O
inflammatory	JJ	amod	O
synovitis	NN	nmod	O
.	.	punct	O

This	DT	det	O
increase	NN	nsubj	O
disappeared	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
cycloheximide	NN	nmod	O
.	.	punct	O

RNA	NN	nsubj	O
from	IN	case	O
control	JJ	amod	O
resting	VBG	amod	B-cell_type
cells	NNS	nmod	I-cell_type
contained	VBD	ROOT	O
low	JJ	dobj	O
to	TO	case	O
undetectable	JJ	amod	O
levels	NNS	nmod	O
of	IN	case	O
c-jun	NN	nmod	B-RNA
,	,	punct	O
fibronectin	NN	compound	B-RNA
receptor	NN	conj	I-RNA
,	,	punct	O
and	CC	cc	O
actin	NN	compound	B-RNA
mRNA	NN	conj	I-RNA
.	.	punct	O

Further	JJ	amod	O
studies	NNS	nsubjpass	O
are	VBP	auxpass	O
needed	VBN	ROOT	O
to	TO	mark	O
elucidate	VB	xcomp	O
if	IN	mark	O
this	DT	det	O
sex	NN	compound	O
difference	NN	nsubj	O
in	IN	case	O
PBMC	NN	compound	B-protein
receptors	NNS	nmod	I-protein
for	IN	case	O
1.25	CD	nummod	O
Dihydroxyvitamin	NN	compound	O
D3	NN	nmod	O
is	VBZ	cop	O
of	IN	case	O
any	DT	det	O
pathophysiological	JJ	amod	O
relevance	NN	nmod	O
.	.	punct	O

The	DT	det	O
normal	JJ	amod	O
upper	JJ	amod	O
limit	NN	nsubj	O
of	IN	case	O
ER	NN	compound	B-protein
content	NN	nmod	O
in	IN	case	O
lymphocytes	NNS	nmod	B-cell_type
,	,	punct	O
expressed	VBN	acl	O
by	IN	case	O
fmol/micrograms	NN	nmod	O
of	IN	case	O
DNA	NN	nmod	O
,	,	punct	O
was	VBD	cop	O
0.136	CD	ROOT	O
.	.	punct	O

Previous	JJ	amod	O
transfection	NN	compound	O
studies	NNS	nsubj	O
of	IN	case	O
HIV	NN	compound	B-DNA
LTR	NN	compound	I-DNA
constructs	NNS	nmod	I-DNA
linked	VBN	acl	O
to	TO	case	O
the	DT	det	O
chloramphenicol	NN	compound	B-DNA
acetyltransferase	NN	compound	I-DNA
gene	NN	nmod	I-DNA
indicated	VBD	ROOT	O
that	IN	mark	O
multiple	JJ	amod	O
regulatory	JJ	amod	B-DNA
regions	NNS	nsubj	I-DNA
including	VBG	case	O
the	DT	det	O
enhancer	NN	nmod	B-DNA
,	,	punct	O
SP1	NN	conj	B-DNA
,	,	punct	O
TATA	NN	conj	B-DNA
and	CC	cc	O
TAR	NN	compound	B-DNA
regions	NNS	conj	I-DNA
were	VBD	cop	O
important	JJ	ccomp	O
for	IN	case	O
HIV	NN	compound	O
gene	NN	compound	O
expression	NN	nmod	O
.	.	punct	O

An	DT	det	O
IRF-1	NN	compound	B-protein
-dependent	JJ	amod	O
pathway	NN	ROOT	O
of	IN	case	O
DNA	NN	compound	O
damage-induced	JJ	amod	O
apoptosis	NN	nmod	O
in	IN	case	O
mitogen-activated	JJ	amod	B-cell_line
T	NN	compound	I-cell_line
lymphocytes	NNS	nmod	I-cell_line
.	.	punct	O

A	DT	det	O
2.3-kb	JJ	amod	B-protein
LCR	NN	nsubjpass	I-protein
in	IN	case	O
the	DT	det	O
human	JJ	amod	B-DNA
adenosine	NN	compound	I-DNA
deaminase	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
ADA	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	compound	I-DNA
first	JJ	amod	I-DNA
intron	NN	nmod	I-DNA
,	,	punct	O
which	WDT	nsubj	O
controls	VBZ	acl:relcl	O
expression	NN	dobj	O
in	IN	case	O
thymocytes	NNS	nmod	B-cell_type
,	,	punct	O
is	VBZ	auxpass	O
composed	VBN	ROOT	O
of	IN	case	O
a	DT	det	O
200-bp	JJ	amod	B-DNA
enhancer	NN	compound	I-DNA
domain	NN	nmod	I-DNA
and	CC	cc	O
extended	VBD	conj	O
flanking	JJ	amod	O
sequences	NNS	dobj	O
that	WDT	nsubj	O
facilitate	VBP	acl:relcl	O
activation	NN	dobj	O
from	IN	case	O
within	IN	case	O
chromatin	NN	nmod	B-DNA
.	.	punct	O

When	WRB	advmod	O
transferred	VBN	advcl	O
to	TO	case	O
a	DT	det	O
potent	JJ	amod	O
activator	NN	nmod	O
,	,	punct	O
transcriptional	JJ	amod	O
stimulation	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
efficiently	RB	advmod	O
.	.	punct	O

Two	CD	nummod	O
distinct	JJ	amod	O
transcription	NN	compound	B-protein
factors	NNS	ROOT	I-protein
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
enhancer	NN	compound	I-DNA
microE5/kappa	NN	compound	B-DNA
2	CD	nummod	I-DNA
motif	NN	dobj	I-DNA
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
level	NN	nsubjpass	O
of	IN	case	O
jun	NN	compound	B-protein
protein	NN	nmod	I-protein
was	VBD	auxpass	O
elevated	VBN	ROOT	O
by	IN	case	O
2	CD	compound	O
to	TO	dep	O
5-fold	RB	nmod	O
within	IN	case	O
4	CD	nummod	O
h	NN	nmod	O
in	IN	case	O
HU	NN	nmod:npmod	B-cell_line
treated	JJ	amod	I-cell_line
cells	NNS	nmod	I-cell_line
.	.	punct	O

The	DT	det	O
calcium	NN	compound	O
ionophore-induced	JJ	amod	O
c-myc	NN	compound	B-DNA
suppression	NN	nsubj	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
strictly	RB	advmod	O
requires	VBZ	ROOT	O
de	FW	amod	O
novo	FW	dep	O
protein	NN	compound	O
synthesis	NN	dobj	O
.	.	punct	O

They	PRP	nsubj	O
propose	VBP	ROOT	O
that	IN	mark	O
BSAP	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
key	JJ	amod	B-protein
protein	NN	ccomp	I-protein
of	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
that	IN	mark	O
it	PRP	nsubj	O
not	RB	neg	O
only	RB	cc:preconj	O
influence	VBP	conj	O
B-cell	NN	compound	O
development	NN	dobj	O
but	CC	cc	O
also	RB	advmod	O
influences	VBZ	conj	O
the	DT	det	O
balance	NN	dobj	O
between	IN	case	O
B-cell	NN	compound	O
proliferation	NN	nmod	O
and	CC	cc	O
immunoglobulin	NN	compound	B-protein
secretion	NN	conj	O
at	IN	case	O
later	JJR	amod	O
stages	NNS	nmod	O
of	IN	case	O
B-cell	NN	compound	O
differentiation	NN	nmod	O
.	.	punct	O

In	IN	case	O
all	DT	det	O
cell	NN	compound	B-cell_line
lines	NNS	nmod	I-cell_line
where	WRB	advmod	O
1	CD	nummod	O
,	,	punct	O
25	CD	conj	O
(	-LRB-	punct	O
OH	NN	appos	O
)	-RRB-	punct	O
2D3	NN	compound	O
binding	NN	nsubj	O
to	TO	case	O
a	DT	det	O
receptor	NN	nmod	B-protein
was	VBD	cop	O
detectable	JJ	ROOT	O
,	,	punct	O
the	DT	det	O
receptor	NN	nsubj	B-protein
had	VBD	parataxis	O
the	DT	det	O
typical	JJ	amod	O
sedimentation	NN	compound	O
coefficient	NN	dobj	O
of	IN	case	O
3.7	CD	nummod	O
S	NN	nmod	O
on	IN	case	O
sucrose	NN	compound	O
density	NN	compound	O
gradient	NN	compound	O
analysis	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
purified	VBN	ROOT	O
a	DT	det	O
new	JJ	amod	O
T-cell-specific	JJ	amod	B-protein
factor	NN	dobj	I-protein
,	,	punct	O
TCF-1	NN	compound	B-protein
alpha	NN	appos	I-protein
,	,	punct	O
that	WDT	nsubjpass	O
is	VBZ	auxpass	O
implicated	VBN	acl:relcl	O
in	IN	case	O
the	DT	det	O
activation	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
encoding	VBG	acl	O
a	DT	det	O
major	JJ	amod	O
component	NN	dobj	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	B-protein
T-cell	NN	compound	I-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
TCR	NN	appos	B-protein
)	-RRB-	punct	O
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
previously	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
9S	NN	nsubj	B-protein
,	,	punct	O
untransformed	JJ	amod	B-protein
progestin	NN	conj	I-protein
,	,	punct	I-protein
estrogen	NN	conj	I-protein
,	,	punct	I-protein
androgen	NN	conj	I-protein
,	,	punct	I-protein
and	CC	cc	I-protein
glucocorticoid	NN	compound	I-protein
receptor	NN	compound	I-protein
complexes	NNS	conj	I-protein
in	IN	case	O
rabbit	NN	nmod	O
uterine	NN	amod	O
and	CC	cc	O
liver	NN	conj	O
cytosols	NNS	conj	O
contain	VBP	ccomp	O
a	DT	det	O
59-kDa	JJ	amod	B-protein
protein	NN	dobj	I-protein
[	-LRB-	punct	O
Tai	NNP	compound	O
,	,	punct	O
P.K.	NNP	dep	O
,	,	punct	O
Maeda	NNP	compound	O
,	,	punct	O
Y.	NNP	conj	O
,	,	punct	O
Nakao	NNP	compound	O
,	,	punct	O
K.	NNP	conj	O
,	,	punct	O
Wakim	NNP	compound	O
,	,	punct	O
N.G.	NNP	conj	O
,	,	punct	O
Duhring	NNP	compound	O
,	,	punct	O
J.L.	NNP	conj	O
,	,	punct	O
&	CC	cc	O
Faber	NNP	compound	O
,	,	punct	O
L.E.	NNP	compound	O
(	-LRB-	punct	O
1986	CD	appos	O
)	-RRB-	punct	O
Biochemistry	NNP	conj	O
25	CD	nummod	O
,	,	punct	O
5269-5275	CD	nummod	O
]	-RRB-	punct	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
Markus	NNP	compound	O
Neurath	NNP	nsubj	O
,	,	punct	O
Eckhard	NNP	compound	O
Stuber	NNP	conj	O
and	CC	cc	O
Warren	NNP	compound	O
Strober	NNP	conj	O
describe	VBP	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
structure	NN	dobj	O
of	IN	case	O
BSAP	NN	nmod	B-protein
and	CC	cc	O
focus	VBP	conj	O
on	IN	case	O
the	DT	det	O
ability	NN	nmod	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
to	TO	mark	O
regulate	VB	acl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
B-cell-specific	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

It	PRP	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
the	DT	det	O
ubiquitin	NN	compound	B-protein
-proteasome	JJ	amod	B-protein
system	NN	nsubjpass	O
is	VBZ	auxpass	O
involved	VBN	ccomp	O
in	IN	case	O
the	DT	det	O
process	NN	nmod	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
the	DT	det	O
specific	JJ	amod	O
enzymes	NNS	nsubj	B-protein
involved	VBN	acl	O
and	CC	cc	O
the	DT	det	O
mechanism	NN	conj	O
of	IN	case	O
limited	JJ	amod	O
proteolysis	NN	nmod	O
,	,	punct	O
in	IN	case	O
which	WDT	nmod	O
half	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
molecule	NN	nmod	O
is	VBZ	auxpass	O
spared	VBN	acl:relcl	O
,	,	punct	O
have	VBP	aux	O
been	VBN	parataxis	O
obscure	JJ	acomp	O
.	.	punct	O

While	IN	mark	O
Ro-VDR	NN	compound	B-cell_line
cells	NNS	nsubj	I-cell_line
showed	VBD	advcl	O
typical	JJ	amod	O
nuclear	JJ	amod	O
localization	NN	dobj	O
of	IN	case	O
the	DT	det	O
unoccupied	JJ	amod	B-protein
1	CD	dep	I-protein
,	,	punct	I-protein
25	CD	nummod	I-protein
(	-LRB-	punct	I-protein
OH	NN	compound	I-protein
)	-RRB-	punct	I-protein
2D3	NN	compound	I-protein
receptor	NN	nmod	I-protein
,	,	punct	O
neither	CC	cc:preconj	O
the	DT	det	O
unoccupied	JJ	nsubjpass	O
nor	CC	cc	O
the	DT	det	O
occupied	JJ	amod	O
receptor	NN	conj	B-protein
from	IN	case	O
A1-VDR	NN	compound	B-cell_line
cells	NNS	nmod	I-cell_line
was	VBD	auxpass	O
completely	RB	advmod	O
localized	JJ	ROOT	O
in	IN	case	O
the	DT	det	O
nucleus	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
point	NN	compound	O
mutations	NNS	nsubj	O
that	WDT	nsubj	O
abolish	VBP	acl:relcl	O
binding	NN	dobj	O
of	IN	case	O
NF-E1	NN	nmod	B-protein
result	VBP	ROOT	O
in	IN	case	O
a	DT	det	O
70	CD	compound	O
%	NN	amod	O
decrease	NN	nmod	O
in	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
a	DT	det	O
megakaryocytic-specific	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
.	.	punct	O

Functional	JJ	amod	O
analysis	NN	ROOT	O
of	IN	case	O
cis-linked	JJ	amod	B-DNA
regulatory	JJ	amod	I-DNA
sequences	NNS	nmod	I-DNA
in	IN	case	O
the	DT	det	O
HLA	NN	compound	B-DNA
DRA	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
by	IN	case	O
transcription	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubjpass	O
and	CC	cc	O
activity	NN	conj	O
of	IN	case	O
NF-kappa	NN	compound	B-protein
B	NN	nmod	I-protein
and	CC	cc	O
Sp1	NN	conj	B-protein
were	VBD	auxpass	O
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
analyzed	VBN	ROOT	O
in	IN	case	O
isolated	VBN	amod	O
T	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
and	CC	cc	O
DCs	NNS	conj	B-cell_type
from	IN	case	O
humans	NNS	nmod	O
and	CC	cc	O
mice	NNS	conj	O
.	.	punct	O

The	DT	det	O
binding	VBG	amod	O
sites	NNS	nsubj	O
and	CC	cc	O
partial	JJ	amod	O
proteolysis	NN	compound	O
profile	NN	conj	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
are	VBP	cop	O
indistinguishable	JJ	ROOT	O
from	IN	case	O
those	DT	nmod	O
of	IN	case	O
the	DT	det	O
erythroid	JJ	amod	B-protein
protein	NN	nmod	I-protein
;	:	punct	O
also	RB	advmod	O
,	,	punct	O
NF-E1	NN	compound	B-RNA
messenger	NN	compound	I-RNA
RNA	NN	nsubj	I-RNA
is	VBZ	cop	O
the	DT	det	O
same	JJ	amod	O
size	NN	dep	O
in	IN	case	O
both	CC	cc:preconj	O
the	DT	dep	O
megakaryocytic	JJ	nmod	B-cell_line
and	CC	cc	I-cell_line
erythroid	JJ	conj	I-cell_line
cell	NN	compound	I-cell_line
lines	NNS	dep	I-cell_line
.	.	punct	O

The	DT	det	O
RpoN	NN	compound	O
mutant	NN	nsubj	O
,	,	punct	O
lacking	VBG	acl	O
pili	NNS	dobj	O
,	,	punct	O
flagella	NNS	conj	O
,	,	punct	O
and	CC	cc	O
nonpilus	JJ	amod	B-protein
adhesins	NNS	conj	I-protein
,	,	punct	O
bound	VBD	ROOT	O
poorly	RB	advmod	O
and	CC	cc	O
was	VBD	cop	O
resistant	JJ	conj	O
to	TO	case	O
ingestion	NN	nmod	O
by	IN	case	O
both	CC	cc:preconj	O
macrophages	NNS	nmod	B-cell_type
and	CC	cc	O
neutrophils	NNS	conj	B-cell_type
.	.	punct	O

Some	DT	nsubjpass	O
of	IN	case	O
these	DT	det	O
complexes	NNS	nmod	O
were	VBD	auxpass	O
demonstrated	VBN	ROOT	O
to	TO	mark	O
contain	VB	xcomp	O
NF-IL6	NN	dobj	B-protein
by	IN	mark	O
using	VBG	advcl	O
anti-C/EBP	JJ	amod	B-protein
beta	NN	compound	I-protein
Abs	NNS	dobj	I-protein
.	.	punct	O

The	DT	det	O
'octamer	NN	nmod:poss	B-DNA
'	POS	punct	I-DNA
sequence	NN	nsubj	I-DNA
,	,	punct	O
ATGCAAAT	NN	appos	O
or	CC	cc	O
its	PRP$	nmod:poss	O
complement	NN	compound	O
ATTTGCAT	NN	conj	O
,	,	punct	O
is	VBZ	cop	O
a	DT	det	O
key	JJ	amod	O
element	NN	ROOT	O
for	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
regulation	NN	nmod	O
of	IN	case	O
immunoglobulin	NN	compound	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
B-lymphocytes	NNS	nmod	B-cell_type
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
a	DT	det	O
number	NN	conj	O
of	IN	case	O
housekeeping	JJ	amod	B-DNA
genes	NNS	nmod	I-DNA
in	IN	case	O
all	DT	det	O
cell	NN	compound	O
types	NNS	nmod	O
.	.	punct	O

Critical	JJ	amod	O
role	NN	ROOT	O
for	IN	case	O
IL-6	NN	nmod	B-protein
.	.	punct	O

The	DT	det	O
same	JJ	amod	O
agents	NNS	nsubj	O
induce	VBP	ROOT	O
transcription	NN	dobj	O
from	IN	case	O
the	DT	det	O
interleukin-2	NN	compound	B-DNA
receptor	NN	compound	I-DNA
alpha-chain	NN	nmod	I-DNA
and	CC	cc	I-DNA
interleukin-2	NN	conj	I-DNA
genes	NNS	dep	I-DNA
,	,	punct	O
depending	VBG	case	O
on	IN	case	O
promoter	NN	compound	B-DNA
elements	NNS	nmod	I-DNA
that	WDT	nsubj	O
bind	VBP	acl:relcl	O
the	DT	det	O
inducible	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	dep	I-protein
NF-kappa	NN	compound	B-protein
B	NN	dobj	I-protein
(	-LRB-	punct	O
or	CC	cc	O
an	DT	det	O
NF-kappa	NN	compound	B-protein
B-like	JJ	amod	I-protein
factor	NN	conj	I-protein
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
expression	NN	nsubj	O
reportedly	RB	advmod	O
occurs	VBZ	ROOT	O
in	IN	case	O
multiple	JJ	amod	O
nonlymphoid	JJ	amod	O
tissues	NNS	nmod	O
during	IN	case	O
murine	JJ	amod	O
embryogenesis	NN	nmod	O
.	.	punct	O

Constitutive	JJ	amod	O
activation	NN	ROOT	O
of	IN	case	O
different	JJ	amod	O
Jak	NN	compound	B-protein
tyrosine	NN	compound	I-protein
kinases	NNS	nmod	I-protein
in	IN	case	O
human	JJ	amod	B-protein
T	NN	compound	I-protein
cell	NN	compound	I-protein
leukemia	NN	compound	I-protein
virus	NN	compound	I-protein
type	NN	compound	I-protein
1	CD	nummod	I-protein
(	-LRB-	punct	I-protein
HTLV-1	NN	compound	I-protein
)	-RRB-	punct	I-protein
tax	NN	compound	I-protein
protein	NN	nmod	I-protein
or	CC	cc	O
virus-transformed	JJ	amod	B-cell_line
cells	NNS	conj	I-cell_line
.	.	punct	O

GCR	NN	nsubj	B-protein
on	IN	case	O
MNL	NN	nmod	B-cell_type
and	CC	cc	O
PML	NN	conj	B-cell_type
in	IN	case	O
6	CD	nummod	O
Yang	NN	compound	O
deficient	JJ	amod	O
patients	NNS	nmod	O
were	VBD	cop	O
3473	CD	ROOT	O
+/-	CC	cc	O
413	CD	conj	O
and	CC	cc	O
4433	CD	conj	O
+/-	CC	cc	O
651	CD	conj	O
sites/cell	NNS	dep	O
respectively	RB	advmod	O
,	,	punct	O
statistically	RB	advmod	O
significant	JJ	amod	O
from	IN	case	O
the	DT	det	O
normal	JJ	amod	O
control	NN	compound	O
group	NN	nmod	O
(	-LRB-	punct	O
4462	CD	dep	O
+/-	CC	cc	O
962	CD	conj	O
and	CC	cc	O
5622	CD	conj	O
+/-	CC	cc	O
782	CD	conj	O
sites/cell	NNS	dep	O
respectively	RB	advmod	O
,	,	punct	O
P	NN	appos	O
less	JJR	amod	O
than	IN	case	O
0.05	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
an	DT	det	O
infectious	JJ	amod	O
molecular	JJ	amod	O
clone	NN	dobj	O
of	IN	case	O
HTLV-II	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
importance	NN	dobj	O
of	IN	case	O
the	DT	det	O
internal	JJ	amod	O
ATGs	NNS	nmod	O
of	IN	case	O
the	DT	det	O
rex	NN	compound	B-DNA
gene	NN	nmod	I-DNA
on	IN	case	O
Rex	NN	compound	B-protein
protein	NN	compound	O
production	NN	nmod	O
and	CC	cc	O
function	NN	conj	O
.	.	punct	O

Lastly	RB	advmod	O
,	,	punct	O
the	DT	det	O
different	JJ	amod	O
mobilities	NNS	nsubj	O
of	IN	case	O
osteoblast	NN	compound	B-protein
nuclear	JJ	amod	I-protein
extract-DNA	JJ	amod	I-protein
complexes	NNS	nmod	I-protein
compared	VBN	case	O
with	IN	case	O
T-cell	NN	compound	B-protein
nuclear	JJ	amod	I-protein
extract-DNA	JJ	amod	I-protein
complexes	NNS	nmod	I-protein
,	,	punct	O
along	IN	case	O
with	IN	case	O
the	DT	det	O
inability	NN	nmod	O
of	IN	case	O
OSF2	NN	nmod	B-protein
to	TO	mark	O
be	VB	auxpass	O
upregulated	VBN	acl	O
by	IN	case	O
retinoic	JJ	amod	O
acid	NN	nmod	O
,	,	punct	O
unlike	IN	case	O
the	DT	det	O
other	JJ	amod	O
PEBP2	NN	compound	B-protein
alpha	NN	compound	I-protein
factors	NNS	nmod	I-protein
,	,	punct	O
suggest	VBP	ROOT	O
that	IN	mark	O
OSF2	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
new	JJ	amod	O
member	NN	ccomp	O
of	IN	case	O
this	DT	det	O
family	NN	nmod	O
of	IN	case	O
transcription	NN	compound	B-protein
factors	NNS	nmod	I-protein
.	.	punct	O

Using	VBG	advcl	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	dobj	O
,	,	punct	O
we	PRP	nsubj	O
showed	VBD	ROOT	O
binding	NN	dobj	O
of	IN	case	O
purified	VBN	amod	O
human	JJ	amod	B-protein
NF-kappa	NN	compound	I-protein
B	NN	nmod	I-protein
and	CC	cc	O
of	IN	case	O
the	DT	det	O
NF-kappa	NN	compound	B-protein
B	NN	conj	I-protein
activated	VBN	acl	O
in	IN	case	O
Jurkat	NN	compound	B-cell_line
T	NN	compound	I-cell_line
cells	NNS	nmod	I-cell_line
to	TO	case	O
an	DT	det	O
oligonucleotide	NN	nmod	O
comprising	VBG	acl	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
promoter	NN	compound	I-DNA
element	NN	dobj	I-DNA
responsible	JJ	amod	O
for	IN	mark	O
mediating	VBG	advcl	O
responsiveness	NN	dobj	O
to	TO	case	O
T-cell-activating	JJ	amod	O
signals	NNS	nmod	O
and	CC	cc	O
tax1	NN	conj	B-protein
.	.	punct	O

We	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	dep	O
myeloid	JJ	nsubj	O
and	CC	cc	O
B	NN	conj	B-protein
cell	NN	compound	I-protein
transcription	NN	compound	I-protein
factor	NN	compound	I-protein
PU.1	NN	dep	B-protein
binds	VBZ	ccomp	O
specifically	RB	advmod	O
to	TO	case	O
this	DT	det	O
site	NN	nmod	O
.	.	punct	O

In	IN	case	O
comparison	NN	nmod	O
,	,	punct	O
isolated	VBN	amod	O
nuclei	NNS	nsubj	O
of	IN	case	O
human	JJ	amod	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
in	IN	case	O
which	WDT	nmod	O
no	DT	neg	O
need	NN	nsubj	O
for	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
this	DT	det	O
gene	NN	nmod	O
exists	VBZ	acl:relcl	O
,	,	punct	O
show	VBP	ROOT	O
barely	RB	advmod	O
hybridization	NN	compound	O
signals	NNS	dobj	O
.	.	punct	O

A	DT	det	O
primary	JJ	amod	O
site	NN	nsubj	O
of	IN	case	O
infection	NN	nmod	O
by	IN	case	O
human	JJ	amod	O
adenoviruses	NNS	nmod	O
is	VBZ	cop	O
lymphoid	JJ	amod	B-cell_type
cells	NNS	ROOT	I-cell_type
.	.	punct	O

TAR	NN	compound	B-DNA
independent	JJ	amod	O
activation	NN	ROOT	O
of	IN	case	O
the	DT	det	O
human	JJ	amod	O
immunodeficiency	NN	compound	O
virus	NN	nmod	O
in	IN	case	O
phorbol	NN	compound	O
ester	NN	nmod:npmod	O
stimulated	JJ	amod	O
T	NN	compound	B-cell_type
lymphocytes	NNS	nmod	I-cell_type
.	.	punct	O

To	TO	mark	O
determine	VB	advcl	O
whether	IN	mark	O
enhancer	NN	compound	B-DNA
elements	NNS	nsubj	I-DNA
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
the	DT	det	O
highly	RB	advmod	O
conserved	VBN	amod	O
octamer	NN	compound	B-DNA
(	-LRB-	punct	I-DNA
OCTA	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
-nucleotide	JJ	amod	I-DNA
motif	NN	nmod	I-DNA
are	VBP	cop	O
important	JJ	ccomp	O
for	IN	case	O
lymphoid-specific	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
immunoglobulin	NN	compound	B-DNA
heavy-chain	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
IgH	NN	appos	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
investigated	VBN	ROOT	O
the	DT	det	O
effect	NN	dobj	O
of	IN	mark	O
mutating	VBG	acl	O
the	DT	det	O
binding	VBG	amod	B-DNA
site	NN	dobj	I-DNA
for	IN	case	O
a	DT	det	O
putative	JJ	amod	B-protein
additional	JJ	amod	I-protein
lymphoid-specific	JJ	amod	I-protein
transcription	NN	compound	I-protein
factor	NN	nmod	I-protein
,	,	punct	O
designated	VBN	acl	O
NF-microB	NN	xcomp	B-protein
,	,	punct	O
in	IN	case	O
the	DT	det	O
murine	JJ	amod	B-DNA
IgH	NN	compound	I-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

Transcriptional	JJ	amod	O
efficiency	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
MSV	NN	compound	B-DNA
LTR	NN	compound	I-DNA
promoter	NN	nmod	I-DNA
containing	VBG	acl	O
this	DT	det	O
disrupted	VBN	amod	O
ets-1	NN	compound	B-DNA
binding	NN	compound	I-DNA
site	NN	dobj	I-DNA
was	VBD	auxpass	O
compared	VBN	ROOT	O
to	TO	case	O
the	DT	det	O
activity	NN	nmod	O
of	IN	case	O
a	DT	det	O
wild-type	JJ	amod	B-DNA
promoter	NN	nmod	I-DNA
in	IN	case	O
mouse	NN	compound	B-cell_type
T	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
in	IN	case	O
culture	NN	nmod	O
,	,	punct	O
and	CC	cc	O
15-	CD	compound	O
to	TO	dep	O
20-fold	JJ	amod	O
reduction	NN	nsubjpass	O
in	IN	case	O
expression	NN	nmod	O
of	IN	case	O
a	DT	det	O
reporter	NN	compound	B-DNA
gene	NN	nmod	I-DNA
was	VBD	auxpass	O
observed	VBN	conj	O
.	.	punct	O

Yet	RB	advmod	O
,	,	punct	O
IL-2	NN	nmod:npmod	B-protein
-driven	JJ	amod	O
proliferation	NN	nsubj	O
remained	VBD	ROOT	O
profoundly	RB	advmod	O
inhibited	VBD	xcomp	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
signaling	NN	compound	O
events	NNS	nsubjpass	O
other	JJ	amod	O
than	IN	case	O
Jak3	NN	compound	B-protein
/Stat	NN	compound	B-protein
activation	NN	nmod	O
had	VBD	aux	O
also	RB	advmod	O
been	VBN	auxpass	O
changed	VBN	ccomp	O
following	VBG	case	O
SE	NN	compound	B-protein
stimulation	NN	nmod	O
.	.	punct	O

Flutamide	NN	ROOT	O
in	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
hirsutism	NN	nmod	O
:	:	punct	O
long-term	JJ	amod	O
clinical	JJ	amod	O
effects	NNS	dep	O
,	,	punct	O
endocrine	JJ	amod	O
changes	NNS	conj	O
,	,	punct	O
and	CC	cc	O
androgen	NN	compound	B-protein
receptor	NN	compound	I-protein
behavior	NN	conj	O
.	.	punct	O

Northern	NN	compound	O
blot	NN	compound	O
analysis	NN	nsubj	O
revealed	VBD	ROOT	O
that	IN	mark	O
BLR2	NN	compound	B-RNA
mRNA	NN	nsubjpass	I-RNA
could	MD	aux	O
be	VB	auxpass	O
highly	RB	advmod	O
stimulated	VBN	ccomp	O
in	IN	case	O
mitogen-	NN	nmod	B-cell_line
and	CC	cc	I-cell_line
anti-CD3-treated	JJ	conj	I-cell_line
peripheral	JJ	amod	I-cell_line
blood	NN	compound	I-cell_line
lymphocytes	NNS	dep	I-cell_line
.	.	punct	O

Microtubule	JJ	compound	O
disruption	NN	nsubj	O
did	VBD	aux	O
not	RB	neg	O
affect	VB	ROOT	O
total	JJ	amod	O
cellular	JJ	amod	O
25	CD	nummod	O
(	-LRB-	punct	O
OH	NN	compound	O
)	-RRB-	punct	O
D3	NN	compound	O
uptake	NN	dobj	O
but	CC	cc	O
reduced	VBD	conj	O
its	PRP$	nmod:poss	O
intracellular	JJ	amod	O
trafficking	VBG	dobj	O
to	TO	case	O
the	DT	det	O
mitochondria	NN	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
concurrent	JJ	amod	O
addition	NN	nsubj	O
of	IN	case	O
iron	NN	nmod	O
(	-LRB-	punct	O
in	IN	case	O
the	DT	det	O
form	NN	nmod	O
of	IN	case	O
ferrous	JJ	amod	O
or	CC	cc	O
ferric	JJ	conj	O
chloride	NN	nmod	O
and	CC	cc	O
other	JJ	amod	O
iron	NN	compound	O
salts	NNS	conj	O
)	-RRB-	punct	O
reversed	VBD	ROOT	O
the	DT	det	O
inhibition	NN	dobj	O
of	IN	case	O
proliferation	NN	nmod	O
caused	VBN	acl	O
by	IN	case	O
tepoxalin	NN	nmod	O
.	.	punct	O

Results	NNS	nsubj	O
from	IN	case	O
site-directed	JJ	amod	O
mutations	NNS	nmod	O
and	CC	cc	O
electrophoretic	JJ	amod	O
mobility	NN	compound	O
shift	NN	compound	O
assays	NNS	conj	O
strongly	RB	advmod	O
suggest	VBP	ROOT	O
that	IN	mark	O
this	DT	det	O
sequence	NN	nsubj	O
mediates	VBZ	ccomp	O
the	DT	det	O
ionomycin-induced	JJ	amod	O
activation	NN	dobj	O
of	IN	case	O
the	DT	det	O
TCRG	NN	compound	B-DNA
enhancer	NN	nmod	I-DNA
.	.	punct	O

Two	CD	nummod	O
consensus	NN	compound	O
sequences	NNS	nsubjpass	O
,	,	punct	O
called	VBN	acl	O
X	NN	compound	B-DNA
and	CC	cc	I-DNA
Y	NN	conj	I-DNA
boxes	NNS	xcomp	I-DNA
,	,	punct	O
capable	JJ	amod	O
of	IN	mark	O
binding	VBG	advcl	O
nuclear	JJ	amod	B-protein
proteins	NNS	dobj	I-protein
and	CC	cc	O
regulating	VBG	conj	O
expression	NN	dobj	O
in	IN	case	O
B	NN	compound	B-cell_type
cells	NNS	nmod	I-cell_type
have	VBP	aux	O
been	VBN	auxpass	O
defined	VBN	ROOT	O
within	IN	case	O
the	DT	det	O
immediate	JJ	amod	O
upstream	JJ	amod	O
region	NN	nmod	O
of	IN	case	O
major	JJ	amod	B-DNA
histocompatibility	NN	compound	I-DNA
complex	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
MHC	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
class	NN	compound	I-DNA
II	CD	nummod	I-DNA
promoters	NNS	nmod	I-DNA
.	.	punct	O

This	DT	det	O
effect	NN	nsubj	O
was	VBD	cop	O
dependent	JJ	ROOT	O
upon	IN	case	O
the	DT	det	O
duration	NN	nmod	O
of	IN	case	O
exposure	NN	nmod	O
to	TO	case	O
L.	FW	nmod	O
donovani	NN	nmod	O
and	CC	cc	O
was	VBD	cop	O
maximal	JJ	conj	O
and	CC	cc	O
complete	JJ	conj	O
at	IN	case	O
16	CD	nummod	O
h	NN	nmod	O
.	.	punct	O

Conserved	VBN	amod	O
upstream	JJ	amod	O
promoter	NN	compound	O
sequences	NNS	nsubj	O
regulate	VBP	ROOT	O
this	DT	det	O
tissue-specific	JJ	amod	O
expression	NN	dobj	O
of	IN	case	O
class	NN	compound	B-DNA
II	CD	nummod	I-DNA
genes	NNS	nmod	I-DNA
.	.	punct	O

In	IN	case	O
two	CD	nummod	O
patients	NNS	nmod	O
,	,	punct	O
VDR	NN	nsubjpass	B-protein
was	VBD	auxpass	O
increased	VBN	ROOT	O
after	IN	case	O
daily	JJ	amod	O
phosphate	NN	compound	O
supplementation	NN	nsubjpass	O
was	VBD	auxpass	O
started	VBN	conj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
sodium	NN	compound	O
salicylate	NN	nsubj	O
blocked	VBD	ROOT	O
the	DT	det	O
LPS-induced	JJ	amod	O
proteolytic	JJ	amod	O
degradation	NN	dobj	O
of	IN	case	O
I	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	compound	I-protein
alpha	NN	nmod	I-protein
,	,	punct	O
which	WDT	nsubj	O
prevented	VBD	acl:relcl	O
the	DT	det	O
nuclear	JJ	amod	O
translocation	NN	dobj	O
of	IN	case	O
c-Rel/p65	NN	compound	B-protein
heterodimers	NNS	nmod	I-protein
.	.	punct	O

Cell-cycle	JJ	amod	O
analysis	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
the	DT	det	O
growth-inhibitory	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
DES	NN	nmod	O
,	,	punct	O
TAM	NN	conj	O
or	CC	cc	O
quercetin	NN	conj	O
was	VBD	cop	O
due	JJ	ccomp	O
to	TO	case	O
a	DT	det	O
blocking	NN	amod	O
effect	NN	nmod	O
in	IN	case	O
the	DT	det	O
G0-G1	JJ	compound	O
phases	NNS	nmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
suggest	VBP	ROOT	O
a	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
IL-2	NN	nsubj	B-protein
binding	VBG	acl	O
to	TO	case	O
its	PRP$	nmod:poss	O
receptor	NN	nmod	O
may	MD	aux	O
activate	VB	acl:relcl	O
specific	JJ	amod	B-DNA
genes	NNS	dobj	I-DNA
involved	VBN	acl	O
in	IN	case	O
immune	JJ	amod	O
cell	NN	compound	O
function	NN	nmod	O
.	.	punct	O

Transient	JJ	amod	O
stimulation	NN	nsubj	O
of	IN	case	O
quiescent	JJ	amod	B-cell_type
B	NN	compound	I-cell_type
lymphocytes	NNS	nmod	I-cell_type
with	IN	case	O
either	CC	cc:preconj	O
a	DT	det	O
cocktail	NN	nmod	O
of	IN	case	O
anti-CD40	NN	nmod	B-protein
,	,	punct	O
anti-IgM	NN	conj	B-protein
,	,	punct	O
and	CC	cc	O
IL4	NN	conj	B-protein
,	,	punct	O
or	CC	cc	O
EBV	NN	conj	O
results	VBZ	ROOT	O
in	IN	case	O
the	DT	det	O
rapid	JJ	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
same	JJ	amod	O
four	CD	nummod	O
genes	NNS	nmod	O
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
,	,	punct	O
after	IN	case	O
infection	NN	nmod	O
,	,	punct	O
EBV	NN	nsubj	O
exploits	VBZ	ccomp	O
the	DT	det	O
normal	JJ	amod	O
program	NN	dobj	O
of	IN	case	O
B-lymphocyte	NN	compound	B-cell_type
cell	NN	compound	O
cycle	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

In	IN	case	O
an	DT	det	O
exploration	NN	nmod	O
of	IN	case	O
the	DT	det	O
potential	JJ	amod	O
role	NN	nmod	O
of	IN	case	O
the	DT	det	O
glucocorticoid	NN	compound	O
receptor	NN	nmod	O
(	-LRB-	punct	O
GR	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
AD	NN	nmod	O
,	,	punct	O
GR	NN	compound	O
density	NN	conj	O
and	CC	cc	O
affinity	NN	conj	O
were	VBD	auxpass	O
assessed	VBN	ROOT	O
on	IN	case	O
mononuclear	JJ	amod	B-cell_type
leukocytes	NNS	nmod	I-cell_type
of	IN	case	O
12	CD	nummod	O
AD	NN	compound	O
patients	NNS	nmod	O
and	CC	cc	O
12	CD	nummod	O
healthy	JJ	amod	O
controls	NNS	conj	O
.	.	punct	O

Proteins	NNS	nsubj	O
exist	VBP	ROOT	O
in	IN	case	O
leukocytes	NNS	nmod	B-cell_type
able	JJ	amod	O
to	TO	mark	O
modify	VB	xcomp	O
GTP-binding	JJ	amod	B-protein
protein	NN	compound	I-protein
function	NN	dobj	O
in	IN	case	O
this	DT	det	O
manner	NN	nmod	O
,	,	punct	O
and	CC	cc	O
their	PRP$	nmod:poss	O
activity	NN	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
regulated	VBN	conj	O
by	IN	case	O
signals	NNS	nmod	O
generated	VBN	acl	O
on	IN	case	O
phagocyte	NN	compound	O
stimulation	NN	nmod	O
.	.	punct	O

Nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
of	IN	amod	I-protein
activated	VBN	amod	I-protein
T	NN	compound	I-protein
cells	NNS	nsubj	I-protein
(	-LRB-	punct	O
NFAT	NN	appos	B-protein
)	-RRB-	punct	O
regulates	VBZ	ROOT	O
transcription	NN	dobj	O
of	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
cytokine	NN	compound	B-protein
genes	NNS	nmod	I-protein
,	,	punct	O
and	CC	cc	O
NFAT	NN	compound	B-protein
DNA	NN	compound	O
binding	NN	compound	O
activity	NN	nsubjpass	O
is	VBZ	auxpass	O
stimulated	VBN	parataxis	O
following	VBG	case	O
T	NN	compound	O
cell	NN	compound	O
activation	NN	nmod	O
.	.	punct	O

The	DT	det	O
mechanisms	NNS	nsubjpass	O
by	IN	case	O
which	WDT	nmod	O
the	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
IL-2	NN	nmod	B-protein
are	VBP	auxpass	O
propagated	VBN	acl:relcl	O
within	IN	case	O
cells	NNS	nmod	O
are	VBP	auxpass	O
not	RB	neg	O
understood	VBN	ROOT	O
.	.	punct	O

In	IN	case	O
most	JJS	amod	O
cases	NNS	nmod	O
,	,	punct	O
the	DT	det	O
transcriptional	JJ	amod	B-protein
factor	NN	compound	I-protein
NF-kappa	NN	compound	B-protein
B	NN	nsubj	I-protein
is	VBZ	cop	O
a	DT	det	O
heterodimer	NN	ROOT	B-protein
consisting	VBG	acl	O
of	IN	case	O
two	CD	nummod	O
subunits	NNS	nmod	O
,	,	punct	O
p50	NN	appos	B-protein
and	CC	cc	O
p65	NN	conj	B-protein
,	,	punct	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
encoded	VBN	acl:relcl	O
by	IN	case	O
two	CD	nummod	O
distinct	JJ	amod	O
genes	NNS	nmod	O
of	IN	case	O
the	DT	det	O
Rel	NN	compound	B-DNA
family	NN	nmod	I-DNA
.	.	punct	O

In	IN	case	O
only	RB	advmod	O
four	CD	nummod	O
patients	NNS	compound	O
sodium	NN	nsubj	O
in	IN	case	O
HML	NNS	nmod	B-cell_type
without	IN	case	O
incubation	NN	nmod	O
was	VBD	cop	O
elevated	JJ	ROOT	O
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
range	NN	nmod	O
for	IN	case	O
normal	JJ	amod	O
persons	NNS	nmod	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
resting	VBG	amod	B-cell_type
PBL	NN	nsubj	I-cell_type
constitutively	RB	advmod	O
expressed	VBD	ROOT	O
prominent	JJ	amod	O
levels	NNS	dobj	O
of	IN	case	O
Id2	NN	compound	B-RNA
mRNA	NN	nmod	I-RNA
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
Id3	NN	compound	B-RNA
mRNA	NN	conj	I-RNA
.	.	punct	O

In	IN	case	O
parallel	JJ	amod	O
experiments	NNS	nmod	O
,	,	punct	O
IL-2	NN	nmod:npmod	B-protein
-driven	JJ	amod	O
proliferation	NN	nsubjpass	O
was	VBD	auxpass	O
inhibited	VBN	ROOT	O
significantly	RB	advmod	O
.	.	punct	O

In	IN	case	O
HIV-1	NN	nmod	O
,	,	punct	O
the	DT	det	O
sequences	NNS	nsubjpass	O
that	WDT	nsubj	O
respond	VBP	acl:relcl	O
to	TO	case	O
these	DT	det	O
signaling	NN	compound	O
events	NNS	nmod	O
are	VBP	auxpass	O
found	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
long	JJ	amod	B-DNA
terminal	JJ	amod	I-DNA
repeat	NN	nmod	I-DNA
(	-LRB-	punct	O
LTR	NN	appos	B-DNA
)	-RRB-	punct	O
and	CC	cc	O
comprise	VBP	conj	O
the	DT	det	O
transcriptional	JJ	amod	B-DNA
enhancer	NN	dobj	I-DNA
,	,	punct	O
which	WDT	nsubj	O
contains	VBZ	acl:relcl	O
two	CD	nummod	O
conserved	VBN	amod	B-DNA
binding	VBG	compound	I-DNA
sites	NNS	dobj	I-DNA
for	IN	case	O
the	DT	det	O
nuclear	JJ	amod	B-protein
factor	NN	compound	I-protein
kappa	NN	compound	I-protein
B	NN	nmod	I-protein
(	-LRB-	punct	O
NF	NN	compound	B-protein
kappa	NN	compound	I-protein
B	NN	appos	I-protein
)	-RRB-	punct	O
.	.	punct	O

PU.1	NN	nsubj	B-protein
is	VBZ	cop	O
a	DT	det	O
hematopoietic	JJ	amod	B-protein
transcription	NN	compound	I-protein
factor	NN	ROOT	I-protein
belonging	VBG	acl	O
to	TO	case	O
the	DT	det	O
Ets-family	NN	nmod	B-protein
.	.	punct	O

This	DT	det	O
``	``	punct	O
octamer	NN	nsubj	B-DNA
``	''	punct	O
in	IN	case	O
the	DT	dep	O
context	NN	dep	O
of	IN	case	O
DRA	NN	nmod	B-protein
appears	VBZ	ROOT	O
capable	JJ	xcomp	O
of	IN	mark	O
binding	VBG	advcl	O
both	CC	cc:preconj	O
the	DT	det	O
ubiquitous	JJ	dobj	B-protein
(	-LRB-	punct	O
OTF-1	NN	appos	B-protein
)	-RRB-	punct	O
and	CC	cc	O
lymphoid-specific	JJ	conj	B-protein
(	-LRB-	punct	I-protein
OTF-2	NN	appos	I-protein
)	-RRB-	punct	I-protein
``	``	punct	I-protein
octamer	NN	compound	I-protein
''	''	punct	I-protein
binding	NN	compound	I-protein
proteins	NNS	dep	I-protein
,	,	punct	O
but	CC	cc	O
at	IN	case	O
least	JJS	nmod:npmod	O
one	CD	nummod	O
other	JJ	amod	O
distinct	JJ	amod	O
``	``	punct	B-protein
octamer	NN	compound	I-protein
''	''	punct	I-protein
complex	NN	nsubjpass	I-protein
was	VBD	auxpass	O
found	VBN	conj	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
molecular	JJ	amod	O
basis	NN	dobj	O
of	IN	case	O
the	DT	det	O
synergistic	JJ	amod	O
induction	NN	nmod	O
by	IN	case	O
interferon-gamma	NN	nmod	B-protein
(	-LRB-	punct	O
IFN-gamma	NN	appos	B-protein
)	-RRB-	punct	O
/	:	punct	O
tumor	NN	compound	B-protein
necrosis	NN	compound	I-protein
factor-alpha	NN	conj	I-protein
(	-LRB-	punct	O
TNF-alpha	NN	appos	B-protein
)	-RRB-	punct	O
of	IN	case	O
human	JJ	amod	B-DNA
interleukin-6	NN	compound	I-DNA
(	-LRB-	punct	I-DNA
IL-6	NN	compound	I-DNA
)	-RRB-	punct	I-DNA
gene	NN	nmod	I-DNA
in	IN	case	O
THP-1	NN	compound	B-cell_type
monocytic	JJ	amod	I-cell_type
cells	NNS	nmod	I-cell_type
,	,	punct	O
and	CC	cc	O
compared	VBD	conj	O
it	PRP	dobj	O
with	IN	case	O
the	DT	det	O
basis	NN	nmod	O
of	IN	case	O
this	DT	det	O
induction	NN	nmod	O
by	IN	case	O
lipopolysaccharide	NN	nmod	O
(	-LRB-	punct	O
LPS	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

(	-LRB-	punct	O
ABSTRACT	NN	ROOT	O
TRUNCATED	VBN	acl	O
AT	IN	case	O
250	CD	nummod	O
WORDS	NNS	nmod	O
)	-RRB-	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
the	DT	det	O
existence	NN	nsubjpass	O
of	IN	case	O
estrogen	NN	compound	B-protein
receptor	NN	nmod	I-protein
(	-LRB-	punct	O
estrogen	NN	compound	O
binding	NN	compound	O
activity	NN	appos	O
)	-RRB-	punct	O
was	VBD	auxpass	O
examined	VBN	ROOT	O
histochemically	RB	advmod	O
in	IN	case	O
39	CD	nummod	O
cases	NNS	nmod	O
and	CC	cc	O
it	PRP	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	conj	O
in	IN	case	O
8	CD	nmod	O
.	.	punct	O

A	DT	det	O
recent	JJ	amod	O
functional	JJ	amod	O
analysis	NN	nsubj	O
by	IN	case	O
Miyatake	NNP	nmod	O
et	FW	dep	O
al.	FW	dep	O
(	-LRB-	punct	O
S.	NNP	compound	O
Miyatake	NNP	dep	O
,	,	punct	O
M.	NNP	compound	O
Seiki	NNP	conj	O
,	,	punct	O
M.	NNP	compound	O
Yoshida	NNP	conj	O
,	,	punct	O
and	CC	cc	O
K.	NNP	compound	O
Arai	NNP	conj	O
,	,	punct	O
Mol.	NNP	compound	O
Cell.	NNP	compound	O
Biol.	NNP	appos	O
8	CD	nummod	O
:	:	punct	O
5581-5587	CD	dep	O
,	,	punct	O
1988	CD	amod	O
)	-RRB-	punct	O
described	VBD	ROOT	O
a	DT	det	O
short	JJ	amod	B-DNA
promoter	NN	compound	I-DNA
region	NN	dobj	I-DNA
in	IN	case	O
the	DT	det	O
GM-CSF	NN	compound	B-DNA
gene	NN	nmod	I-DNA
that	WDT	nsubj	O
conferred	VBD	acl:relcl	O
strong	JJ	amod	O
inducibility	NN	dobj	O
by	IN	case	O
T-cell-activating	JJ	amod	O
signals	NNS	nmod	O
and	CC	cc	O
tax1	NN	conj	B-protein
,	,	punct	O
but	CC	cc	O
no	DT	neg	O
NF-kappa	NN	compound	B-DNA
B-binding	JJ	amod	I-DNA
motifs	NNS	nsubjpass	I-DNA
were	VBD	auxpass	O
identified	VBN	conj	O
.	.	punct	O

The	DT	det	O
role	NN	ROOT	O
of	IN	case	O
BSAP	NN	nmod	B-protein
(	-LRB-	punct	O
Pax-5	NN	appos	B-protein
)	-RRB-	punct	O
in	IN	case	O
B-cell	NN	compound	O
development	NN	nmod	O
.	.	punct	O

Each	DT	det	O
binding	VBG	compound	B-DNA
site	NN	nsubj	I-DNA
contributes	VBZ	ROOT	O
to	TO	case	O
the	DT	det	O
overall	JJ	amod	O
activity	NN	nmod	O
of	IN	case	O
the	DT	det	O
enhancer	NN	nmod	B-DNA
,	,	punct	O
however	RB	advmod	O
no	DT	neg	O
single	JJ	amod	O
element	NN	nsubj	O
seems	VBZ	parataxis	O
absolutely	RB	advmod	O
required	VBN	xcomp	O
for	IN	case	O
activity	NN	nmod	O
.	.	punct	O

A	DT	det	O
truncation	NN	compound	B-protein
mutant	NN	nsubj	I-protein
of	IN	case	O
LEF-1	NN	nmod	B-protein
(	-LRB-	punct	O
HMG-88	NN	appos	B-protein
)	-RRB-	punct	O
,	,	punct	O
which	WDT	nsubj	O
contains	VBZ	acl:relcl	O
the	DT	det	O
HMG	NN	compound	B-protein
box	NN	dobj	I-protein
but	CC	cc	O
lacks	VBZ	conj	O
the	DT	det	O
trans-activation	NN	compound	B-protein
domain	NN	dobj	I-protein
,	,	punct	O
did	VBD	aux	O
not	RB	neg	O
activate	VB	ROOT	O
transcription	NN	dobj	O
from	IN	case	O
nucleosomal	JJ	amod	B-DNA
DNA	NN	nmod	I-DNA
,	,	punct	O
indicating	VBG	advcl	O
that	IN	mark	O
bending	NN	nsubj	O
of	IN	case	O
DNA	NN	nmod	O
by	IN	case	O
the	DT	det	O
HMG	NN	compound	B-protein
domain	NN	nmod	I-protein
is	VBZ	cop	O
not	RB	neg	O
sufficient	JJ	ccomp	O
to	TO	mark	O
activate	VB	xcomp	O
transcription	NN	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

NF-X2	NN	nsubj	B-protein
that	WDT	nsubj	O
binds	VBZ	acl:relcl	O
to	TO	case	O
the	DT	det	O
DRA	NN	compound	B-DNA
X2-box	NN	nmod	I-DNA
is	VBZ	cop	O
activator	NN	compound	B-protein
protein	NN	ROOT	I-protein
1	CD	nummod	I-protein
.	.	punct	O

[	-LRB-	punct	O
Endocrine	JJ	amod	O
status	NN	compound	O
changes	NNS	ROOT	O
in	IN	case	O
children	NNS	nmod	O
with	IN	case	O
bronchial	JJ	amod	O
asthma	NN	nmod	O
]	-RRB-	punct	O

LPS	NN	nsubj	O
is	VBZ	cop	O
not	RB	neg	O
able	JJ	ROOT	O
to	TO	mark	O
induce	VB	xcomp	O
HIV-1	NN	compound	O
production	NN	dobj	O
in	IN	case	O
a	DT	det	O
cloned	VBN	amod	O
T	NN	compound	B-cell_line
cell	NN	compound	I-cell_line
line	NN	nmod	I-cell_line
.	.	punct	O

HTLV-1	NN	compound	O
infection	NN	nsubj	O
causes	VBZ	ROOT	O
an	DT	det	O
adult	JJ	amod	O
T	NN	compound	O
cell	NN	compound	O
leukemia	NN	dobj	O
in	IN	case	O
humans	NNS	nmod	O
.	.	punct	O

